<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">ppat</journal-id><journal-title>PLoS Pathogens</journal-title><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.ppat.0030100</article-id><article-id pub-id-type="publisher-id">07-PLPA-RA-0045R2</article-id><article-id pub-id-type="sici">plpa-03-07-06</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Infectious Diseases</subject><subject>Infectious Diseases</subject><subject>Infectious Diseases</subject><subject>Microbiology</subject></subj-group><subj-group subj-group-type="System Taxonomy"><subject>In Vitro</subject><subject>Eukaryotes</subject></subj-group></article-categories><title-group><article-title>Integrin-Mediated Host Cell Invasion by Type 1&#x02013;Piliated Uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content></article-title><alt-title alt-title-type="running-head">UPEC Invasion via Integrin Receptors</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eto</surname><given-names>Danelle S</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Tiffani A</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Sundsbak</surname><given-names>Jamie L</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Mulvey</surname><given-names>Matthew A</given-names></name><xref ref-type="corresp" rid="cor1">&#x0002a;</xref><xref rid="aff1" ref-type="aff"/></contrib></contrib-group><aff id="aff1">Division of Cell Biology and Immunology, Pathology Department, University of Utah, Salt Lake City, Utah, United States of America</aff><contrib-group><contrib contrib-type="editor"><name><surname>Isberg</surname><given-names>Ralph R</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">Tufts University School of Medicine, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <email>mulvey&#x00040;path.utah.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>13</day><month>7</month><year>2007</year></pub-date><volume>3</volume><issue>7</issue><elocation-id>e100</elocation-id><history><date date-type="received"><day>24</day><month>1</month><year>2007</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2007</year></date></history><copyright-statement><bold>Copyright:</bold> &#x000a9; 2007 Eto et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2007</copyright-year><abstract><p>Uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content> (UPEC), the primary causative agent of urinary tract infections, typically express filamentous adhesive organelles called type 1 pili that mediate both bacterial attachment to and invasion of bladder urothelial cells. Several host proteins have previously been identified as receptors for type 1 pili, but none have been conclusively shown to promote UPEC entry into host bladder cells. Using overlay assays with FimH, the purified type 1 pilus adhesin, and mass spectroscopy, we have identified &#x003b2;1 and &#x003b1;3 integrins as key host receptors for UPEC. FimH recognizes N-linked oligosaccharides on these receptors, which are expressed throughout the urothelium. In a bladder cell culture system, &#x003b2;1 and &#x003b1;3 integrin receptors co-localize with invading type 1&#x02013;piliated bacteria and F-actin. FimH-mediated bacterial invasion of host bladder cells is inhibited by &#x003b2;1 and &#x003b1;3 integrin&#x02013;specific antibodies and by disruption of the &#x003b2;1 integrin gene in the GD25 fibroblast cell line. Phosphorylation site mutations within the cytoplasmic tail of &#x003b2;1 integrin that alter integrin signaling also variably affect UPEC entry into host cells, by either attenuating or boosting invasion frequencies. Furthermore, focal adhesion and Src family kinases, which propagate integrin-linked signaling and downstream cytoskeletal rearrangements, are shown to be required for FimH-dependent bacterial invasion of target host cells. Cumulatively, these results indicate that &#x003b2;1 and &#x003b1;3 integrins are functionally important receptors for type 1 pili&#x02013;expressing bacteria within the urinary tract and possibly at other sites within the host.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><sec id="st1"><title/><p>Strains of bacteria called uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content> (UPEC) are the primary cause of urinary tract infections (UTIs), which by some estimates are the second most common type of infectious disease in the world today. UPEC strains typically express hair-like fibers called type 1 pili on their surface that allow them to bind and invade the host cells that line the urinary tract. The ability of UPEC to enter these host cells likely promotes the establishment and persistence of UTIs. The invasion process requires that the incoming pathogens first bind specific receptor molecules on the target cell surface. Here, we identify two host proteins known as &#x003b2;1 and &#x003b1;3 integrin as key receptors for type 1 pili&#x02013;expressing UPEC. The adhesive tips of type 1 pili recognize sugars that decorate these integrin receptors, thereby activating a signaling cascade that stimulates the host plasma membrane to zipper around and envelop bound bacteria. &#x003b2;1 and &#x003b1;3 integrins have important roles in a number of host cell functions and are widely distributed within the urinary tract and in other tissues. Interestingly, type 1 pili are expressed by many different types of bacteria in addition to UPEC, raising the possibility that interactions between type 1 pili and integrin receptors can facilitate bacterial colonization within diverse niches throughout the host.</p></sec></abstract><counts><page-count count="13"/></counts><custom-meta-wrap><custom-meta><meta-name>citation</meta-name><meta-value>Eto DS, Jones TA, Sundsbak JL, Mulvey MA (2007) Integrin-mediated host cell invasion by type 1&#x02013;piliated uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content>. PLoS Pathog 3(7): e100. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.ppat.0030100">10.1371/journal.ppat.0030100</ext-link></meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Host cell invasion contributes to the ability of many bacterial pathogens to colonize, multiply, disseminate, and, in some cases, persist for weeks to months within their animal hosts. In recent years, many bacteria that had previously been characterized as strictly extracellular microbes have been shown to behave as opportunistic intracellular pathogens &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b001">1</xref>&#x0005d;. Among these invasive bacteria are strains of uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content> (UPEC). Worldwide, UPEC accounts for the majority of urinary tract infections (UTIs), including both cystitis (bladder infection) and pyelonephritis (kidney infection) &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b002">2</xref>&#x0005d;. These infections are exceedingly common in females, affecting about 11&#x00025; of women each year &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b003">3</xref>&#x0005d;. The propensity of these infections to recur adds greatly to their problematic nature. By some estimates, more than 25&#x00025; of women will endure a second UTI within 6 mo of an initial bladder infection, and about 3&#x00025; will experience a third &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b004">4</xref>,<xref ref-type="bibr" rid="ppat-0030100-b005">5</xref>&#x0005d;. Cell culture and mouse UTI model systems suggest that UPEC invasion of host tissues within the urinary tract contributes significantly to the establishment as well the persistence and recurrence of UTIs &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b006">6</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b013">13</xref>&#x0005d;.</p><p>UPEC are now known to utilize a number of diverse mechanisms to enter host epithelial cells &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b001">1</xref>,<xref ref-type="bibr" rid="ppat-0030100-b014">14</xref>&#x0005d;. These mechanisms include manipulation of host Rho GTPases by the secreted UPEC-associated toxin CNF1 &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b015">15</xref>&#x0005d;, the hijacking, via opsonization, of host complement receptors &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b016">16</xref>,<xref ref-type="bibr" rid="ppat-0030100-b017">17</xref>&#x0005d;, and the expression by UPEC of filamentous adhesive organelles known as type 1 pili &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. Virtually all UPEC isolates and many other species within the Enterobacteriaceae family encode type 1 pili (also known as type 1 fimbriae) &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b019">19</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b021">21</xref>&#x0005d;. These peritrichously expressed organelles are composite fibers made up of a 7-nm-wide helical rod comprised of repeating FimA subunits joined to a distal 3-nm-thick tip fibrillum consisting of two adaptor proteins, FimF and FimG, and the adhesin FimH &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b022">22</xref>,<xref ref-type="bibr" rid="ppat-0030100-b023">23</xref>&#x0005d;. Type 1 pili, and in particular the FimH adhesin, are critical to the ability of UPEC to effectively colonize the urinary tract &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b008">8</xref>,<xref ref-type="bibr" rid="ppat-0030100-b019">19</xref>,<xref ref-type="bibr" rid="ppat-0030100-b024">24</xref>,<xref ref-type="bibr" rid="ppat-0030100-b025">25</xref>&#x0005d;.</p><p>FimH possesses an N-terminal carbohydrate-binding pocket that enables type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content> to bind mannose-containing host glycoprotein receptors and thereby mediate both bacterial adherence to and invasion of target host cells &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>,<xref ref-type="bibr" rid="ppat-0030100-b026">26</xref>&#x0005d;. Studies using <italic>fimH</italic>-null mutants and purified FimH have demonstrated that this adhesin is sufficient for mediating <named-content content-type="genus-species">E. coli</named-content> entry into bladder epithelial cells &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. Once internalized, UPEC is trafficked into membrane-bound acidic compartments with many features that are characteristic of late endosomes and lysosomes &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b010">10</xref>,<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. Within these compartments, UPEC replication is restricted. However, upon entry into the host cytosol, UPEC can rapidly multiply, forming large biofilm-like inclusions that occupy much of the host cell interior &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b006">6</xref>,<xref ref-type="bibr" rid="ppat-0030100-b009">9</xref>,<xref ref-type="bibr" rid="ppat-0030100-b010">10</xref>,<xref ref-type="bibr" rid="ppat-0030100-b027">27</xref>&#x0005d;. These inclusions are known variably as bacterial factories, pods, or intracellular bacterial communities and are often observed in mouse UTI models within the terminally differentiated superficial umbrella cells that line the lumenal surface of the bladder. Umbrella cells, along with two to three layers of underlying immature basal and intermediate epithelial cells, comprise the urothelium.</p><p>The stratified cell layers of the urothelium act as a formidable permeability barrier, restricting the diffusion of solutes from urine into associated tissue &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b028">28</xref>&#x0005d;. However, during the course of a UTI, this barrier is compromised due to the induced exfoliation of infected superficial umbrella cells and the influx of immune cells &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b001">1</xref>,<xref ref-type="bibr" rid="ppat-0030100-b008">8</xref>,<xref ref-type="bibr" rid="ppat-0030100-b013">13</xref>&#x0005d;. Consequently, UPEC is able to penetrate beyond the superficial cell layer and invade underlying immature host cells &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b009">9</xref>,<xref ref-type="bibr" rid="ppat-0030100-b010">10</xref>&#x0005d;. UPEC growth within these epithelial cells is limited, and the bacteria seem to enter a more quiescent state that is in part modulated by the host actin cytoskeleton. We have hypothesized that UPEC that manage to invade and persist quiescently within the immature cells of the bladder urothelium act as a source for recurrent acute UTIs &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b010">10</xref>&#x0005d;.</p><p>How FimH promotes UPEC invasion of bladder epithelial cells is not entirely clear. Cell culture studies have revealed that FimH-mediated host cell invasion requires phosphoinositide 3-kinase (PI 3-kinase) activation and localized host actin rearrangements &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. Rho GTPases and lipid rafts are also implicated in the invasion process, along with focal adhesion kinase (FAK) activation and transient complex formation between the cytoskeleton stabilizing and scaffolding components &#x003b1;-actinin and vinculin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>,<xref ref-type="bibr" rid="ppat-0030100-b029">29</xref>,<xref ref-type="bibr" rid="ppat-0030100-b030">30</xref>&#x0005d;. However, the FimH host receptor(s) involved in initiating the cascade of signaling events leading to UPEC entry into bladder epithelial cells is unknown. FimH interactions with several glycosylated and nonglycosylated host factors have been documented. These include components of the glycocalyx that sparsely covers the bladder surface &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b031">31</xref>&#x0005d;, a few extracellular matrix (ECM) proteins &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b032">32</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b034">34</xref>&#x0005d;, carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family members &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b035">35</xref>,<xref ref-type="bibr" rid="ppat-0030100-b036">36</xref>&#x0005d;, soluble Tamm-Horsfall protein &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b037">37</xref>&#x0005d;, the glycosylphosphatidylinositol (GPI)-anchored protein CD48 &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b038">38</xref>,<xref ref-type="bibr" rid="ppat-0030100-b039">39</xref>&#x0005d;, the leukocyte adhesion molecules CD11 and CD18 &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b040">40</xref>&#x0005d;, and uroplakin 1a (UP1a) &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b041">41</xref>&#x0005d;. Here, we identify &#x003b2;1 and &#x003b1;3 integrins, which are distributed throughout the urothelium, as key mediators of host cell invasion by type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content>. In addition, we show that FimH-mediated bacterial entry into host cells is modulated by specific phosphorylation sites within the cytoplasmic tail of &#x003b2;1 integrin and by downstream integrin-linked signaling factors.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Identification of Potential FimH Receptors</title><p>To search for host receptors that might promote FimH-mediated bacterial invasion of bladder epithelial cells, we first purified the FimH adhesin. FimH is assembled into the distal tips of type 1 pili via a canonical chaperone-usher pathway &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b023">23</xref>,<xref ref-type="bibr" rid="ppat-0030100-b042">42</xref>&#x0005d;. In the absence of the periplasmic chaperone FimC, FimH, as well as other type 1 pilus subunits, misfold and are subsequently degraded. In order to purify native full-length FimH, the adhesin was coordinately expressed in BL21(DE3) <named-content content-type="genus-species">E. coli</named-content> cells with FimC, which was doubly tagged with consecutive COOH-terminal 6XHis and FLAG epitopes. These tags facilitated the purification of FimC&#x02013;FimH complexes using affinity chromatography and allowed for cleaner detection of the complexes in later Far Western overlay assays.</p><p>Next, host membrane-associated proteins isolated from a human bladder epithelial cell line designated 5637 were resolved by SDS-PAGE and transferred to polyvinylidene fluoride (PVDF) membranes. These membranes were incubated with purified FimC<sub>6XHisFLAG</sub> or with FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes in the presence or absence of 2.5&#x00025; D-mannose, which acts as a soluble FimH receptor analog. All blots were subsequently probed using an anti-FLAG antibody and chemiluminescence. In these Far Western overlay assays, no bands were bound by purified FimC<sub>6XHisFLAG</sub> alone or by FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes in the presence of D-mannose (<xref ref-type="fig" rid="ppat-0030100-g001">Figure 1</xref>). However, in the absence of D-mannose, approximately 15 bands bound by FimC<sub>6XHisFLAG</sub>&#x02013;FimH were detected. The mannose sensitivity of these interactions, as well as the lack of FimC<sub>6XHisFLAG</sub> binding, indicates that they are mediated by FimH and not FimC. The two most prominent bands bound by FimH (<xref ref-type="fig" rid="ppat-0030100-g001">Figure 1</xref>, bracketed) had molecular weights of approximately 120 and 150 kDa. These bands were excised from a duplicate GelCode Blue&#x02013;stained gel, trypsin digested, and shown by mass spectroscopy to be composed of (in order of prevalence of the detected peptides) &#x003b1;2, &#x003b2;1, &#x003b1;3, &#x003b1;6, and &#x003b2;4 integrins. The presence of &#x003b2;4 integrin&#x02013;specific sequences within these bands is surprising since this integrin has an apparent molecular weight of over 200 kDa, substantially above the range of the isolated 120- and 150-kDa bands. Nevertheless, we did not use this discrepancy as a basis to exclude &#x003b2;4 integrin as a FimH receptor candidate.</p><fig id="ppat-0030100-g001" position="float"><label>Figure 1</label><caption><title>Identification of Potential FimH Receptors</title><p>Membrane-associated proteins isolated from 5637 bladder epithelial cells were resolved by SDS-PAGE and transferred to PVDF membrane. Protein bands bound by purified recombinant FimC<sub>6XHisFLAG</sub> alone (left) or FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes in the presence (middle) and absence (right) of 2.5&#x00025; D-mannose were detected by chemiluminescence in overlay assays using anti-FLAG antibody. The two most prominent bands bound by the FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes were found by mass spectroscopy analysis to be comprised of &#x003b1;2, &#x003b2;1, &#x003b1;3, &#x003b1;6, and &#x003b2;4 integrins. Molecular weight standards are indicated on the left.</p></caption><graphic xlink:href="ppat.0030100.g001"/></fig><p>Integrins are surface adhesion molecules, comprised of &#x003b1; and &#x003b2; subunit heterodimers, that connect ECM proteins with the actin cytoskeleton &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b043">43</xref>&#x0005d;. Currently, there are 18 known &#x003b1; and eight &#x003b2; subunits that can combine to form at least 24 different heterodimeric integrin complexes with varying ligand-binding specificities. &#x003b2; subunits, and in particular &#x003b2;1, can interact with multiple &#x003b1; subunits. Many pathogens, including human cytomegalovirus, Group A Streptococcus, <named-content content-type="genus-species">Yersinia</named-content> spp., and AfaD<sup>&#x0002b;</sup><italic>E. coli,</italic> gain entry into target host cells by binding integrins either directly or indirectly via matrix proteins such as fibronectin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b044">44</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b050">50</xref>&#x0005d;. Our data from Far Western overlay assays, which were performed in the absence of any established integrin ligands, suggest that FimH is able to directly interact in a mannose-sensitive fashion with one or more of the five integrin subunits identified above.</p></sec><sec id="s2b"><title>Antibodies against &#x003b2;1 and &#x003b1;3 Integrins Inhibit Host Cell Invasion by UPEC</title><p>To test the functional role of the putative FimH receptors (&#x003b2;1, &#x003b2;4, &#x003b1;2, &#x003b1;3, and &#x003b1;6 integrins) in mediating UPEC entry into host cells, we employed a modified gentamicin protection&#x02013;based invasion assay (see <xref ref-type="sec" rid="s4">Materials and Methods</xref> and &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b051">51</xref>&#x0005d;). 5637 bladder epithelial cells were incubated with monoclonal antibodies directed against specific integrin subunits prior to infection with either UTI89, a well-characterized human cystitis isolate &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b006">6</xref>,<xref ref-type="bibr" rid="ppat-0030100-b009">9</xref>,<xref ref-type="bibr" rid="ppat-0030100-b010">10</xref>,<xref ref-type="bibr" rid="ppat-0030100-b027">27</xref>,<xref ref-type="bibr" rid="ppat-0030100-b052">52</xref>&#x0005d;, or AAEC185/pSH2, a type 1 pili&#x02013;expressing recombinant laboratory K-12 <named-content content-type="genus-species">E. coli</named-content> strain &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b008">8</xref>,<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. Both UTI89 and AAEC185/pSH2 require expression of the FimH adhesin in order to adhere to and effectively invade bladder epithelial cells. We found that a &#x003b2;1 integrin&#x02013;blocking antibody, 6S6, notably decreased UTI89 invasion of host 5637 bladder epithelial cells (<xref ref-type="fig" rid="ppat-0030100-g002">Figure 2</xref>A). The &#x003b2;1 integrin&#x02013;activating antibody P4G11 and the anti&#x02013;&#x003b1;3 integrin antibody P1B5 had similar effects in inhibiting bacterial invasion. Antibodies against the other putative FimH receptors (&#x003b1;2, &#x003b1;6, and &#x003b2;4 integrins) did not significantly affect UTI89 entry into the bladder epithelial cells and served as convenient isotype controls. Similar invasion results were observed in complementary experiments using AAEC185/pSH2. Both the &#x003b2;1 integrin&#x02013;blocking antibody 6S6 and the anti&#x02013;&#x003b1;3 integrin antibody P1B5 notably attenuated AAEC185/pSH2 invasion of 5637 cells, while an anti&#x02013;&#x003b1;2 integrin control antibody had no effect (<xref ref-type="fig" rid="ppat-0030100-g002">Figure 2</xref>C). None of the antibodies had any significant effect on the total numbers of cell-associated bacteria, with the exception of the anti&#x02013;&#x003b1;3 integrin antibody, which for unknown reasons caused a slight increase in the numbers of cell-associated AAEC185/pSH2 (<xref ref-type="fig" rid="ppat-0030100-g002">Figure 2</xref>B and <xref ref-type="fig" rid="ppat-0030100-g002">2</xref>D). Increasing the concentration of the antibodies used by up to 8-fold gave similar results in both the invasion and adherence assays. Importantly, control studies showed that none of the antibodies utilized in these assays cross-reacted or interfered with either the growth or viability of UTI89 and AAEC185/pSH2. The combined use of anti&#x02013;&#x003b1;3 and anti&#x02013;&#x003b2;1 integrin antibodies did not have a cumulative inhibitory effect on UTI89 invasion (unpublished data).</p><fig id="ppat-0030100-g002" position="float"><label>Figure 2</label><caption><title>Anti&#x02013;&#x003b2;1 and Anti&#x02013;&#x003b1;3 Integrin Antibodies Inhibit Host Cell Invasion by Type 1&#x02013;Piliated <named-content content-type="genus-species">E. coli</named-content></title><p>5637 bladder epithelial cell monolayers were treated with 1.5 &#x003bc;g/well of the indicated monoclonal antibodies for 30 min prior to infection with the UPEC cystitis isolate UTI89 or AAEC185/pSH2, a type 1 pili&#x02013;expressing recombinant K-12 strain. Shown are (A and C) intracellular bacterial titers, determined using gentamicin protection assays, and (B and D) total cell-associated bacteria (including both intra- and extracellular bacteria). Data are expressed as the means &#x000b1; standard error of the mean of at least three independent experiments carried out in triplicate. &#x0002a; <italic>p</italic> &#x0003c; 0.001, versus untreated control (Ctrl) values, as determined by Student's <italic>t</italic>-test.</p></caption><graphic xlink:href="ppat.0030100.g002"/></fig></sec><sec id="s2c"><title>Localization of Type 1&#x02013;Piliated <named-content content-type="genus-species">E. coli</named-content> with &#x003b2;1 and &#x003b1;3 Integrins</title><p>Immunofluorescence confocal microscopy was used to determine whether &#x003b2;1 and &#x003b1;3 integrin subunits localize in bladder epithelial cells with adherent and/or invading type 1 pili&#x02013;expressing <named-content content-type="genus-species">E. coli</named-content>. 5637 bladder cells were infected for 30 min with either the cystitis isolate UTI89 or AAEC185/pSH2. Samples were stained using primary antibodies specific for the individual &#x003b2;1 and &#x003b1;3 subunits or for &#x003b1;3&#x003b2;1 heterodimeric complexes. Fluorescently tagged phalloidin was used to visualize F-actin. Analysis of single cross sections from confocal <italic>z</italic>-stacks revealed that &#x003b2;1 and &#x003b1;3 subunits, as well as &#x003b1;3&#x003b2;1 heterodimers and F-actin, co-localize around adherent and invading UTI89 (<xref ref-type="fig" rid="ppat-0030100-g003">Figure 3</xref>A&#x02013;<xref ref-type="fig" rid="ppat-0030100-g003">3</xref>C). In addition, F-actin and &#x003b1;3&#x003b2;1 integrin heterodimers were also found in association with type 1&#x02013;piliated bacteria that had already penetrated into the bladder epithelial cells, below the host cell surface (<xref ref-type="fig" rid="ppat-0030100-g003">Figure 3</xref>D). Similar results were seen with AAEC185/pSH2-infected bladder cells (<xref ref-type="fig" rid="ppat-0030100-g003">Figure 3</xref>E&#x02013;<xref ref-type="fig" rid="ppat-0030100-g003">3</xref>G). In contrast, bacterial co-localization with F-actin and the &#x003b1;3 and &#x003b2;1 integrin subunits was not detected in bladder cells infected with either of the <italic>fimH</italic>-null mutants <italic>&#x00394;fimH</italic> UTI89 or AAEC185/pUT2002. These results suggest a scenario in which FimH-mediated clustering of &#x003b1;3&#x003b2;1 integrin receptors triggers localized actin rearrangements that lead to the envelopment and internalization of type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content>.</p><fig id="ppat-0030100-g003" position="float"><label>Figure 3</label><caption><title>Localization of &#x003b2;1 and &#x003b1;3 Integrins with Type 1 Pili&#x02013;Expressing <named-content content-type="genus-species">E. coli</named-content></title><p>5637 bladder cells were infected for 30 min with (A&#x02013;D) UTI89 or (E&#x02013;G) AAEC185/pSH2 prior to fixation and processing for immunofluorescent confocal microscopy. Samples were stained using antibodies specific for the following individual integrin subunits: (A and E) &#x003b2;1, (B and F) &#x003b1;3, or (C, D and G) heterodimeric &#x003b1;3&#x003b2;1 integrin complexes (green in the merged color images). F-actin (red) was visualized using Alexa568-conjugated phalloidin, while bacteria (blue) were detected using anti&#x02013;<named-content content-type="genus-species">E. coli</named-content> antibody. For clarity, the merged color image in each row is accompanied by images showing only corresponding single channel signals from integrin or F-actin staining. Arrowheads denote the location of an individual bacterium in each set of images. Based on optical sectioning, the highlighted bacteria in (A&#x02013;C) and (E&#x02013;G) were localized at or very near the host cell surface, while the bacteria in (D) have already completely penetrated the target host cell.</p><p>Scale bar &#x0003d; 10 &#x003bc;m.</p></caption><graphic xlink:href="ppat.0030100.g003"/></fig></sec><sec id="s2d"><title>Glycosidase Treatment of &#x003b2;1 and &#x003b1;3 Integrins Abrogates FimH Binding</title><p>The capacity of FimH to act as a lectin and bind mannose-containing structures is critical to its role as a mediator of bacterial adherence and invasion &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>,<xref ref-type="bibr" rid="ppat-0030100-b053">53</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b055">55</xref>&#x0005d;. Our data suggest that FimH binds &#x003b2;1 and &#x003b1;3 integrin receptors directly, presumably via interactions with one or more of the N-linked sugar side chains that decorate these host glycoproteins. To further test this possibility, &#x003b2;1 and &#x003b1;3 integrins were immunoprecipitated from 5637 bladder cells that had been transfected with expression constructs encoding either V5His-tagged human &#x003b2;1 or untagged &#x003b1;3 integrin. Immunoprecipitates were split up and mock treated or treated with either of the glycosidases EndoHf or PNGase F. Samples were then resolved by SDS-PAGE and transferred to PVDF membranes. EndoHf cleaves high mannose and hybrid oligosaccharides from N-linked glycoproteins, while PNGase F cleaves all N-linked sugars. Western blot analysis using anti&#x02013;&#x003b2;1 and anti&#x02013;&#x003b1;3 integrin antibodies showed that the glycosidase treatments caused large decreases in the apparent molecular weights of both integrins, reflective of their deglycosylated status (<xref ref-type="fig" rid="ppat-0030100-g004">Figure 4</xref>A and <xref ref-type="fig" rid="ppat-0030100-g004">4</xref>B). In Far Western overlay assays, purified FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes interacted poorly or not at all with the deglycosylated forms of the &#x003b2;1 and &#x003b1;3 integrins, but bound well to the untreated integrin bands. Neither FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes in the presence of 2.5&#x00025; D-mannose nor FimC<sub>6XHisFLAG</sub> alone bound to the untreated &#x003b2;1 and &#x003b1;3 integrin bands (<xref ref-type="fig" rid="ppat-0030100-g004">Figure 4</xref>A and <xref ref-type="fig" rid="ppat-0030100-g004">4</xref>B). The faint bands seen in the Far Western blot shown in <xref ref-type="fig" rid="ppat-0030100-g004">Figure 4</xref>B may reflect weak interactions between FimH and deglycosylated or partially glycosylated forms of &#x003b1;3 integrin&#x02014;these faint bands were not detected in the presence of D-mannose or when blots were incubated with only purified FimC<sub>6XHisFLAG</sub>. Cumulatively, these results demonstrate that FimH can directly bind both &#x003b2;1 and &#x003b1;3 integrin subunits individually and that these interactions are highly dependent on the presence of N-linked oligosaccharides.</p><fig id="ppat-0030100-g004" position="float"><label>Figure 4</label><caption><title>Glycosidase Treatment Abrogates In Vitro Binding of FimH to &#x003b2;1 and &#x003b1;3 Integrins</title><p>(A) &#x003b2;1 and (B) &#x003b1;3 integrins were immunoprecipitated from 5637 cells that had been transiently transfected with plasmids for overexpression of recombinant human &#x003b2;1 or &#x003b1;3 integrins. The immunoprecipitated proteins were treated &#x000b1; glycosidases (endoglycosidase Hf &#x0005b;EndoHf&#x0005d; or Peptide: N-glycosidase F &#x0005b;PNGase&#x0005d;) prior to SDS-PAGE and transfer to PVDF membranes. Blots were probed with either (A) anti&#x02013;&#x003b2;1 or (B) anti&#x02013;&#x003b1;3 integrin antibodies (Westerns), revealing expected shifts in the electrophoretic mobility of both integrin subunits following glycosidase treatments. For each set of samples, duplicate blots were overlaid with purified recombinant FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes and probed with anti-FLAG tag antibody (Far Westerns). As additional controls, blots containing untreated &#x003b2;1 or &#x003b1;3 integrins were also incubated with either FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes plus 2.5&#x00025; D-mannose or with FimC<sub>6XHisFLAG</sub> alone. Molecular weight standards are indicated on the left.</p></caption><graphic xlink:href="ppat.0030100.g004"/></fig></sec><sec id="s2e"><title>Phosphorylation Sites within the Cytoplasmic Tail of &#x003b2;1 Integrin Modulate Entry of Type 1&#x02013;Piliated <named-content content-type="genus-species">E. coli</named-content></title><p>To confirm and further define the role of &#x003b2;1 integrin as a facilitator of host cell invasion by type 1&#x02013;piliated <italic>E. coli,</italic> we performed cell association and gentamicin protection&#x02013;based invasion assays with a mouse embryonic fibroblast cell line, GD25, in which the gene encoding &#x003b2;1 integrin has been inactivated &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b056">56</xref>,<xref ref-type="bibr" rid="ppat-0030100-b057">57</xref>&#x0005d;. Comparisons were made with a stably transfected derivative of the GD25 cell line, GD25-&#x003b2;1A, that encodes the widely expressed wild-type &#x003b2;1 integrin splice variant, &#x003b2;1A. In these and related assays described below, the number of intracellular bacteria recovered was divided by the number of total cell-associated bacteria as a means to normalize the data, accounting for possible variations in host cell numbers &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b051">51</xref>&#x0005d;. Entry of UTI89, as well as the type 1&#x02013;piliated K-12 strain AAEC185/pSH2, into the &#x003b2;1 integrin&#x02013;null GD25 cells was significantly decreased relative to the control GD25-&#x003b2;1A cells (<xref ref-type="fig" rid="ppat-0030100-g005">Figure 5</xref>A and <xref ref-type="fig" rid="ppat-0030100-g005">5</xref>C). In contrast, the numbers of cell-associated bacteria did not notably differ between these two host cell lines (<xref ref-type="fig" rid="ppat-0030100-g005">Figure 5</xref>B and <xref ref-type="fig" rid="ppat-0030100-g005">5</xref>D). These data verify that &#x003b2;1 integrin is a major, but probably not an exclusive, mediator of host cell invasion by type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content> strains.</p><fig id="ppat-0030100-g005" position="float"><label>Figure 5</label><caption><title>&#x003b2;1 Integrin Cytoplasmic Tail Mutants Differentially Affect FimH-Mediated Bacterial Invasion of Host Cells</title><p>&#x003b2;1 integrin&#x02013;null GD25 cells, as well as GD25 derivatives that constitutively express wild-type or the indicated mutant forms of &#x003b2;1 integrin, were infected with (A and B) UTI89 or (C and D) AAEC185/pSH2. Levels of intracellular bacteria (A and C) were normalized among the different host cell lines by dividing the numbers of intracellular, gentamicin-protected bacteria by the number of total cell-associated bacteria (B and D). Data are expressed relative to results from GD25-&#x003b2;1A control cells and represent the means &#x000b1; standard error of the mean of at least five independent experiments performed in triplicate. &#x0002a; <italic>p</italic> &#x0003c; 0.001, versus values from control GD25-&#x003b2;1A cells, as determined by Student's <italic>t</italic>-test.</p></caption><graphic xlink:href="ppat.0030100.g005"/></fig><p>&#x003b2;1 integrin contains five potential phosphorylation sites (Y783, S785, T788, T789, and Y795) within the terminal 16 amino acids of its cytoplasmic tail &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b058">58</xref>&#x0005d;. Mutation of these phosphorylation sites can variably affect cellular attachment to ECM components as well as cell spreading and migration &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b058">58</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b060">60</xref>&#x0005d;. To address the roles of these phosphorylation sites within the cytoplasmic tail of &#x003b2;1 integrin in host cell invasion by type 1&#x02013;piliated <italic>E. coli,</italic> we utilized three derivatives of the GD25 cell line: GD25-&#x003b2;1A<sub>TT788/9A</sub>, GD25-&#x003b2;1A<sub>Y783/795F</sub>, and GD25-&#x003b2;1A<sub>S785A</sub> cells. GD25-&#x003b2;1A<sub>TT788/9A</sub> cells have T to A mutations at threonine residues T788 and T789 within the cytoplasmic tail of &#x003b2;1A integrin that render the ligand-binding extracellular domain of this integrin inactive and unable to mediate cellular adhesion to laminin and fibronectin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b058">58</xref>,<xref ref-type="bibr" rid="ppat-0030100-b059">59</xref>&#x0005d;. In GD25-&#x003b2;1A<sub>Y783/795F</sub> cells, tyrosine residues Y783 and Y795 of &#x003b2;1A integrin have been replaced with phenylalanines, resulting in decreased cell migration presumptively due to reduced activation of FAK, a key regulator of focal adhesion and actin dynamics &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b061">61</xref>&#x0005d;. In GD25-&#x003b2;1A<sub>S785A</sub> cells, serine residue S785 within the tail of &#x003b2;1A integrin was mutated to alanine. While no glaring phenotypic effect due to this particular amino acid substitution has been reported yet, other mutations at this site indicate a role for S785 phosphorylation as a modulator of cell attachment, spreading, and migration &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b060">60</xref>&#x0005d;.</p><p>Results from invasion assays using GD25-&#x003b2;1A<sub>TT788/9A</sub>, GD25-&#x003b2;1A<sub>Y783/795F</sub>, and GD25-&#x003b2;1A<sub>S785A</sub> cells infected with either UTI89 or AAEC185/pSH2 are included as part of <xref ref-type="fig" rid="ppat-0030100-g005">Figure 5</xref>A and <xref ref-type="fig" rid="ppat-0030100-g005">5</xref>C. Similar trends were observed for both UTI89- and AAEC185/pSH2-infected samples. Relative to the GD25-&#x003b2;1A cells, bacterial entry into both GD25-&#x003b2;1A<sub>Y783/795F</sub> and GD25-&#x003b2;1A<sub>TT788/9A</sub> cells was significantly reduced. In contrast, bacterial invasion of GD25-&#x003b2;1<sub>S785A</sub> host cells was notably and reproducibly enhanced. The numbers of total bacteria that could associate with these different host cell lines were similar, with the exception of the GD25-&#x003b2;1<sub>S785A</sub> cells (<xref ref-type="fig" rid="ppat-0030100-g005">Figure 5</xref>B and <xref ref-type="fig" rid="ppat-0030100-g005">5</xref>D). On average, nearly twice as many type 1&#x02013;piliated bacteria associated with the GD25-&#x003b2;1<sub>S785A</sub> cells in comparison with the parent GD25 cells.</p><p>Flow cytometry analysis confirmed that the GD25 cell line lacked &#x003b2;1 integrin surface expression and also revealed some variation in the levels of &#x003b2;1 integrin surface expression among the different GD25 derivatives (<xref ref-type="table" rid="ppat-0030100-t001">Table 1</xref>). Higher levels of &#x003b2;1 integrin expression on the surface of GD25-&#x003b2;1<sub>S785A</sub> cells may contribute to their relative enhanced capacity to bind and internalize type 1&#x02013;piliated bacteria. However, &#x003b2;1 integrin expression levels did not necessarily correlate with the ability of the bacteria to either associate with or invade the other GD25 cell line derivatives (<xref ref-type="fig" rid="ppat-0030100-g005">Figure 5</xref> and <xref ref-type="table" rid="ppat-0030100-t001">Table 1</xref>). For example, in our experiments, GD25-&#x003b2;1A<sub>Y783/795F</sub> cells consistently expressed higher levels of surface-localized &#x003b2;1 integrin than GD25-&#x003b2;1<sub>S785A</sub> cells, yet the GD25-&#x003b2;1A<sub>Y783/795F</sub> cells were bound by fewer bacteria and were considerably less susceptible to invasion by type 1 pili&#x02013;expressing <named-content content-type="genus-species">E. coli</named-content>. Cumulatively, these data indicate that phosphorylation site-specific mutations within the &#x003b2;1 integrin cytoplasmic tail can differentially affect host cell invasion by type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content> strains. However, these effects are not entirely attributable to variances in receptor availability or bacterial adhesion frequencies and may instead be a consequence of aberrant integrin-linked signaling events.</p><table-wrap id="ppat-0030100-t001" content-type="1col" position="float"><label>Table 1</label><caption><p>&#x003b2;1 Integrin Expression as Determined by Flow Cytometry</p></caption><graphic xlink:href="ppat.0030100.t001"/></table-wrap></sec><sec id="s2f"><title>Host Cell Invasion by Type 1&#x02013;Piliated <named-content content-type="genus-species">E. coli</named-content> Requires Src and FAK</title><p>Ligand-induced clustering and activation of integrin receptors can stimulate a number of signal transduction pathways that often rely on Src family kinases and FAK &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b062">62</xref>,<xref ref-type="bibr" rid="ppat-0030100-b063">63</xref>&#x0005d;. The engagement of integrin receptors promotes autophosphorylation of FAK at tyrosine 397, creating a high-affinity binding site for several Src homology 2 (SH2) domain-containing proteins, including Src tyrosine kinase. Binding to FAK stimulates Src kinase activity, which in turn promotes further phosphorylation and maximal activation of FAK. The resultant dual-activated Src&#x02013;FAK signaling complex acts to recruit and/or phosphorylate several adaptor and signaling factors that can modulate a variety of host cell functions, including actin dynamics. This link between integrin receptors and downstream signaling through Src family kinases and FAK suggested a role for these tyrosine kinases in FimH-mediated invasion of host cells by UPEC. To address this possibility, we first investigated the involvement of Src family kinases in UPEC invasion using two structurally related Src family kinase inhibitors, PP1 and PP2 &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b064">64</xref>&#x0005d;. Treatment with either PP1 or PP2 greatly inhibited the ability of UTI89 to invade 5637 bladder epithelial cells (<xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref>A). In contrast, treatment of host cells with PP3, an inactive analog of both PP1 and PP2, had almost no effect. Notably, these compounds did not interfere with bacterial association with the host cells (<xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref>B) and did not affect host cell or bacterial viability during the course of the experiments (unpublished data).</p><fig id="ppat-0030100-g006" position="float"><label>Figure 6</label><caption><title>FimH-Mediated Bacterial Invasion of Host Cells Requires Src Family Kinases and FAK</title><p>(A and B) 5637 cells were treated with 20 &#x003bc;g/ml of the Src family kinase inhibitors PP1 or PP2 or with an inactive analog, PP3, for 1 h prior to infection with UTI89. Levels of intracellular bacteria as determined by gentamicin protection assays (A) or total cell-associated bacteria (B) are expressed relative to results from cells treated with carrier (DMSO) alone.</p><p>(C and D) Alternately, 5637 cells were transfected with either scrambled control siRNA or siRNA with specificity against FAK. Cells were infected with UTI89 at 72 h after siRNA transfection and intracellular (C) and total cell-associated (D) bacterial counts were determined. FAK knockdown was verified by Western blot analysis using antibody specific for total FAK (&#x0005b;C&#x0005d;, inset). Blots were also probed using anti-actin antibody as a protein loading control.</p><p>(E and F) Intracellular (E) and total cell-associated (F) bacteria were also quantified in assays using FAK&#x02212;/&#x02212; and control FAK&#x0002b;/&#x0002b; mouse embryo fibroblasts. Intracellular bacterial levels were normalized in all assays by dividing the numbers of intracellular, gentamicin-protected bacteria by the number of total cell-associated bacteria. Data are expressed relative to results from the indicated control samples and represent the means &#x000b1; standard error of the mean of three independent experiments performed in triplicate. &#x0002a; <italic>p</italic> &#x0003c; 0.001, versus values from control samples, as determined by Student's <italic>t</italic>-test.</p></caption><graphic xlink:href="ppat.0030100.g006"/></fig><p>To examine the role of FAK in host cell invasion by type 1&#x02013;piliated UPEC, 5637 bladder cells were transfected with small interfering RNA (siRNA) specific for FAK or with control scrambled nonspecific siRNA. After 72 h, bacterial invasion and cell association assays were performed using the siRNA-transfected cells. FAK knockdown significantly reduced the ability of UTI89 to enter host 5637 cells by about 40&#x00025; (<xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref>C), but did not affect the total numbers of host cell-associated bacteria (<xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref>D). Knockdown of FAK protein expression was verified by Western blot analysis, which indicated an approximately 65&#x00025; reduction in FAK levels relative to levels of control samples that were transfected with nonspecific siRNA (<xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref>C, inset). To confirm the results from these siRNA experiments, we employed a mouse embryo fibroblast cell line that that does not express FAK (FAK&#x02212;/&#x02212; cells) &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b065">65</xref>&#x0005d;. FAK&#x0002b;/&#x0002b; fibroblasts derived from littermates of the FAK&#x02212;/&#x02212; cell line progenitors were used as a control. UTI89 invasion of the FAK&#x02212;/&#x02212; cells was substantially inhibited relative to control cells (<xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref>E), while total numbers of cell-associated bacteria did not significantly vary between the two host cell lines (<xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref>F). Together, the results presented in <xref ref-type="fig" rid="ppat-0030100-g006">Figure 6</xref> demonstrate a requirement for both Src family kinases and FAK during FimH-mediated host cell invasion by UPEC.</p></sec></sec><sec id="s3"><title>Discussion</title><p>In this study, we show that &#x003b2;1 and &#x003b1;3 integrins mediate entry of type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content> into host cells. While other receptors for FimH have been previously identified, to our knowledge &#x003b2;1 and &#x003b1;3 integrins are the first demonstrated to be functionally important for UPEC invasion of uroepithelial cells. As a heterodimer, &#x003b1;3&#x003b2;1 integrin can bind a number of ECM components, including laminin, fibronectin, and collagen &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b066">66</xref>&#x0005d;. Recognition of ECM proteins allows many pathogens to interact indirectly with host integrin receptors &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b045">45</xref>&#x0005d;. FimH itself is able to bind the matrix-associated proteins laminin, fibronectin, and type IV collagens, which could in turn link UPEC with integrin receptors &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b032">32</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b034">34</xref>&#x0005d;. However, our results using Far Western overlay assays indicate that FimH can directly engage both &#x003b2;1 and &#x003b1;3 integrins, without the need for ECM components to bridge the interactions.</p><p>The carbohydrate-binding pocket at the distal tip of the adhesion domain of FimH accommodates &#x003b1;-linked mannose, either in free form or at the non-reducing end of a glycan &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b026">26</xref>,<xref ref-type="bibr" rid="ppat-0030100-b067">67</xref>&#x0005d;. Integrins can be differentially glycosylated depending on the cell line or cell type observed, and the number and types of glycosylations can affect integrin conformation and function &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b068">68</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b074">74</xref>&#x0005d;. Within their extracellular domains, the &#x003b2;1 and &#x003b1;3 integrin subunits have 12 and 13 putative N-linked glycosylation sites, respectively, and in the case of &#x003b2;1 integrin, ten of the 12 potential N-glycosylation sites appear to be utilized &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b075">75</xref>&#x0005d;. The N-linked glycans associated with both &#x003b2;1 and &#x003b1;3 subunits from different normal and cancerous urothelial cell lines are quite heterogeneous, with complex type oligosaccharides predominating over high-mannose type structures &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b072">72</xref>,<xref ref-type="bibr" rid="ppat-0030100-b076">76</xref>&#x0005d;. In the normal human urothelial cell line HCV29, the high-mannose glycans associated with both &#x003b2;1 and &#x003b1;3 subunits have terminally exposed mannose residues &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b076">76</xref>&#x0005d;. Although integrins with high-mannose type glycans constitute only a small fraction of the total integrin pool, the types of high-mannose structures present on this fraction are representative of those that are potentially able to interact with FimH. In particular, these high-mannose type glycans (Man<sub>8</sub>GlcNAc<sub>2</sub> in both &#x003b1;3 and &#x003b2;1 integrin, along with Man<sub>6</sub>GlcNAc<sub>2</sub> and Man<sub>7</sub>GlcNAc2 structures in &#x003b2;1 integrin) are similar to those that decorate an established FimH receptor, UP1a &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b077">77</xref>&#x0005d;.</p><p>We have found that FimH binding to both &#x003b1;3 and &#x003b2;1 integrin subunits is competitively inhibited by the soluble receptor analog D-mannose, which suggests that the carbohydrate-binding pocket of the adhesin mediates FimH-integrin interactions. Furthermore, enzymatic deglycosylation of the integrin subunits abrogates interactions with FimH in overlay assays. Together, these results indicate that FimH recognizes one or more N-linked high-mannose oligosaccharides associated with each of the target integrins. The ability of FimH to bind the &#x003b1;3 and &#x003b2;1 subunits separately indicates that these interactions occur independently of the canonical ligand-binding pocket formed by intact &#x003b1;3&#x003b2;1 receptor heterodimers. Fine mapping of the interactions between FimH and the &#x003b1;3 and &#x003b2;1 integrin subunits awaits further studies.</p><p>The engagement of extracellular ligands induces integrin clustering, which in turn can enhance the ligand binding avidity of integrin receptors as well as activate downstream signaling events &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b043">43</xref>,<xref ref-type="bibr" rid="ppat-0030100-b078">78</xref>&#x0005d;. Previous work has already suggested that FimH-mediated invasion of bladder epithelial cells involves the induced clustering of host receptors &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b014">14</xref>,<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. By transmission electron microscopy, electron-dense material, which likely represents receptors and other host proteins, accumulates in the host membrane beneath adherent bacteria and FimH-coated beads as they are internalized. Results from immunofluorescence microscopy presented here indicate that &#x003b1;3&#x003b2;1 integrin heterodimers in bladder epithelial cells co-localize around adherent and invading type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content> (see <xref ref-type="fig" rid="ppat-0030100-g003">Figure 3</xref>). We have also noted the accumulation of F-actin around adherent and internalized bacteria in association with the integrin receptors.</p><p>F-actin dynamics are modulated downstream of integrin clustering by the recruitment and/or activation of a number of adaptor proteins, Rho family GTPases and kinases &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b079">79</xref>&#x0005d;. Several of these factors have been implicated as regulators of host cell invasion by type 1&#x02013;piliated bacteria. These include the actin adaptor and bundling components vinculin and &#x003b1;-actinin, the Rho GTPases Cdc42 and Rac1, PI 3-kinase, and FAK &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>,<xref ref-type="bibr" rid="ppat-0030100-b029">29</xref>&#x0005d;. Infection of bladder epithelial cells with type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content> stimulates phosphorylation of FAK at Y397 and promotes transient complex formation between FAK and PI 3-kinase &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. Interactions with FAK activate PI 3-kinase and thereby elicit the generation of 3-phosphoinositide second messengers that can alter actin cytoskeletal dynamics via a number of direct and indirect mechanisms &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b080">80</xref>&#x02013;<xref ref-type="bibr" rid="ppat-0030100-b082">82</xref>&#x0005d;. Pharmacological inhibition of PI 3-kinase activity using either wortmannin or LY294002 has been shown to greatly reduce invasion of 5637 bladder cells by type 1&#x02013;piliated bacteria &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. Here, using siRNA and a FAK-null cell line, we have demonstrated that FAK itself is also required for FimH-mediated entry of UPEC into host cells. Maximal activation of FAK is stimulated by interactions with Src family kinases &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b062">62</xref>,<xref ref-type="bibr" rid="ppat-0030100-b063">63</xref>&#x0005d;. We have found that inhibition of Src family kinases using either the PP1 or PP2 inhibitor significantly interferes with FimH-mediated invasion of host bladder cells by UPEC. In contrast, an inactive analog of these inhibitors had only a modest effect. It should be noted that, for unknown reasons, a previous study using only the PP1 inhibitor failed to indicate a role for Src family kinases in FimH-mediated bacterial invasion &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;.</p><p>FAK positively and negatively regulates multiple signaling molecules, including the Rho family GTPases Rac1 and Cdc42 &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b062">62</xref>&#x0005d;. Both of these GTPases appear to modulate FimH-dependent bacterial invasion of host bladder cells in possible conjunction with &#x003b1;-actinin and vinculin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b029">29</xref>&#x0005d;. The adaptor protein &#x003b1;-actinin is itself a substrate for FAK, and the infection of bladder cells with type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content> stimulates complex formation between &#x003b1;-actinin and vinculin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>&#x0005d;. These complexes can crosslink actin stress fibers and tether them to integrin receptor complexes via interactions with integrin-binding proteins such as paxillin and talin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b063">63</xref>&#x0005d;. The recruitment of FAK and these various other host factors to the cytoplasmic tails of integrins appears to be temporally and spatially regulated by a number of different mechanisms, including phosphorylation. Mutational analyses of threonine, tyrosine, and serine residues within the cytoplasmic tail of &#x003b2;1 integrin indicate variable roles for these putative phosphorylation sites during host cell invasion by type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content>.</p><p>Threonine residues T788 and T789 modulate the active conformation of the extracellular domain of &#x003b2;1 integrin via a so-called inside-out signaling process &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b058">58</xref>&#x0005d;. Inside-out signaling occurs when cytoplasmic signals confer a large conformational change to the integrin extracellular domain, converting the integrin from an inactive state to an active, high-affinity ligand-binding receptor &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b078">78</xref>&#x0005d;. The replacement of threonine residues T788 and T789 in the tail of &#x003b2;1 integrin with alanines alters the extracellular domain of the receptor so that it is inactive and can no longer bind fibronectin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b058">58</xref>&#x0005d;. It is speculated that in wild-type cells, the phosphorylation of T788 and/or T789 is one means by which integrin inside-out signaling is regulated &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b058">58</xref>,<xref ref-type="bibr" rid="ppat-0030100-b083">83</xref>&#x0005d;. We have found that expression of the TT788/789AA mutant &#x003b2;1 integrin renders host cells refractory to invasion by type 1&#x02013;piliated <named-content content-type="genus-species">E. coli</named-content>. Potentially, FimH interactions with &#x003b2;1 integrin in its activated state better promotes bacterial entry.</p><p>Tyrosine residues Y783 and Y795 within the cytoplasmic tail of &#x003b2;1 integrin may influence FimH-mediated bacterial invasion of host cells by altering both inside-out and outside-in signaling processes. Y783 and Y795 are part of two highly conserved NPxY motifs within the tail of &#x003b2; integrin subunits that act as specific binding sites for phosphotyrosine-binding domain-containing proteins, including &#x003b2;1 integrin cytoplasmic domain associated protein-1 and the focal adhesion components tensin and talin &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b084">84</xref>,<xref ref-type="bibr" rid="ppat-0030100-b085">85</xref>&#x0005d;. Binding of talin to NPxY motifs is thought to be required for inside-out activation of &#x003b2; integrins &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b086">86</xref>&#x0005d;. Mutation of the two tyrosines within the NPxY motifs of &#x003b2;1 integrin to alanines (Y783/795A) results in the complete loss of &#x003b2;1 integrin function &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b087">87</xref>,<xref ref-type="bibr" rid="ppat-0030100-b088">88</xref>&#x0005d;. In contrast, the replacement of these tyrosine residues with phenylalanines (Y783/795F), which partially mimic the hydrophobic aromatic ring structure of tyrosine and cannot be phosphorylated, preserves &#x003b2;1 integrin function during development in vivo &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b089">89</xref>,<xref ref-type="bibr" rid="ppat-0030100-b087">87</xref>&#x0005d;. These results indicate that the phosphorylation of Y783 and Y795 is not required for proper &#x003b2;1 integrin function under normal physiological conditions. However, earlier studies indicated that activation of FAK and cell migration is diminished in cultured cells that express &#x003b2;1A<sub>Y783/795F</sub> integrin, which suggests that phosphorylation of Y783 and Y795 can alter integrin function in some situations &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b059">59</xref>,<xref ref-type="bibr" rid="ppat-0030100-b061">61</xref>&#x0005d;. In our assays, FimH-dependent bacterial invasion of GD25-&#x003b2;1A<sub>Y783/795F</sub> host cells was significantly inhibited relative to control cells expressing wild-type &#x003b2;1 integrin. Similar results were previously reported for <italic>Staphylococcus aureus,</italic> a pathogen that invades host cells via &#x003b1;5&#x003b2;1 integrin receptors &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b090">90</xref>&#x0005d;. These findings contrast with those reported for <italic>Yersinia</italic> invasin-mediated entry into host cells via &#x003b2;1 integrin receptors, where the Y783/795F mutations were inconsequential &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b091">91</xref>&#x0005d;. The basis for these contrary outcomes is not clear, but they may reflect variations in the ways in which different bacterial pathogens engage and signal through integrin receptors.</p><p>In contrast to the T788/789A and Y783/795F mutations, the S785A mutation in the tail of &#x003b2;1 integrin significantly enhanced FimH-dependent bacterial invasion frequencies, which corresponded to a degree with increases in the number of total host cell&#x02013;associated bacteria. Surface expression of &#x003b2;1 integrin in the GD25-&#x003b2;1A<sub>S785A</sub> cell line was somewhat elevated relative to that of GD25-&#x003b2;1A control cells, and this could contribute to the observed effects. In addition, the S785A mutation may boost bacterial invasion frequencies by altering integrin-mediated signaling events. For example, it has been shown that mutations at S785 that mimic either de-phosphorylated or phosphorylated forms of serine differentially affect cell attachment, spreading, and migration &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b060">60</xref>&#x0005d;. Based on these observations, we suggest that S785 is an important regulator of &#x003b2;1 integrin signaling during FimH-mediated bacterial invasion, but the specific mechanism by which this residue affects the invasion process is not yet clear.</p><p>A critical feature of any host receptor is its location and availability on cells and within tissues that are targeted by incoming pathogens. As shown here, and by others &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b072">72</xref>,<xref ref-type="bibr" rid="ppat-0030100-b076">76</xref>&#x0005d;, both &#x003b2;1 and &#x003b1;3 integrins are expressed by undifferentiated bladder epithelial cells. Furthermore, Southgate and colleagues have found that both &#x003b2;1 and &#x003b1;3 integrins are expressed in all strata of urothelia from the bladder, ureter, and renal pelvis &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b092">92</xref>&#x0005d;. Thus, &#x003b2;1 and &#x003b1;3 integrin subunits are well situated to act as receptors for UPEC entry into both the terminally differentiated superficial umbrella cells and the underlying immature cells of the urothelium. However, it is likely that other host proteins can also promote UPEC invasion of host urothelial cells. For example, in addition to &#x003b2;1 and &#x003b1;3 integrins, three other integrin subunits (&#x003b1;2, &#x003b1;6, and &#x003b2;4) are also prevalent within the normal human urothelium &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b092">92</xref>&#x0005d; and were picked up as potential FimH receptors in our initial screen. It is conceivable that one or more of these other integrin subunits may also facilitate FimH-mediated bacterial entry, but this was not demonstrable using available antibodies.</p><p>Due to its prevalence within the urinary tract, UP1a has received substantial attention as the canonical FimH receptor. Interestingly, UP1a is a member of a superfamily of membrane proteins known as tetraspanins that often complex with &#x003b2;1 integrin receptors &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b093">93</xref>&#x0005d;. It is thought that tetraspanins modulate integrin-dependent signaling as well as integrin trafficking and compartmentalization within lipid rafts on the cell surface. As already noted, FimH-mediated bacterial invasion of host bladder cells is apparently dependent upon lipid rafts &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b030">30</xref>&#x0005d;. Another tetraspanin protein, CD151, forms a particularly strong association with &#x003b1;3&#x003b2;1 receptors and potentiates integrin ligand-binding activity &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b094">94</xref>,<xref ref-type="bibr" rid="ppat-0030100-b095">95</xref>&#x0005d;. CD151/&#x003b1;3&#x003b2;1 integrin complexes interact with the complement receptor CD46 (membrane cofactor protein), a host protein that has recently been shown to enhance the efficacy of type 1 pilus&#x02013;mediated bacterial invasion of human urinary tract epithelial cells &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b016">16</xref>,<xref ref-type="bibr" rid="ppat-0030100-b096">96</xref>&#x0005d;. These observations suggest the existence of an interconnected web of host receptors, co-receptors, and signaling molecules that can be recruited by type 1&#x02013;piliated UPEC in order to facilitate its entry into target urothelial cells.</p><p>In addition to their roles as mediators of cell attachment, migration, and spreading, integrins are also important modulators of many other processes, including differentiation and apoptosis &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b043">43</xref>&#x0005d;. The capacity of FimH to bind &#x003b1;3&#x003b2;1 integrin, and perhaps other integrin subunits within the urothelium, raises the possibility that FimH effects extend beyond host cell adherence and invasion during the course of a UTI. For example, FimH interactions with &#x003b1;3&#x003b2;1 integrin at intercellular junctions could conceivably expedite bladder cell exfoliation and disruption of the urothelium barrier, a phenomenon that may promote UPEC dissemination within the urinary tract &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b001">1</xref>,<xref ref-type="bibr" rid="ppat-0030100-b008">8</xref>&#x0005d;. Furthermore, the recognition of &#x003b1;3&#x003b2;1 receptors by FimH may also modulate bacteria&#x02013;host interactions outside the urinary tract. In addition to UPEC, most other extraintestinal pathogenic <named-content content-type="genus-species">E. coli</named-content> isolates and many other members of the Enterobacteriaceae family (including both commensal and pathogenic organisms) encode type 1 pili. These microbes are therefore potentially capable of binding and manipulating &#x003b1;3&#x003b2;1 integrin receptors that are expressed by a number of different host cell types and tissues within varied niches throughout the host.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Cell lines, bacterial strains, and plasmids.</title><p>The human bladder epithelial cell line 5637 (ATCC HTB-9; American Type Culture Collection, <ext-link ext-link-type="uri" xlink:href="http://www.atcc.org/">http://www.atcc.org/</ext-link>) was maintained in RPMI 1640 medium (Invitrogen, <ext-link ext-link-type="uri" xlink:href="http://www.invitrogen.com/">http://www.invitrogen.com/</ext-link>) supplemented with 10&#x00025; heat inactivated fetal bovine serum (FBS) (HyClone, <ext-link ext-link-type="uri" xlink:href="http://www.hyclone.com/">http://www.hyclone.com/</ext-link>) at 37 &#x000b0;C in 5&#x00025; CO<sub>2</sub>. The &#x003b2;1 integrin&#x02013;null cell line GD25 and its stably transfected &#x003b2;1 integrin&#x02013;expressing derivatives GD25-&#x003b2;1A, GD25-&#x003b2;1A<sub>S785A</sub>, GD25-&#x003b2;1A<sub>TT788/9A</sub>, and GD25-&#x003b2;1A<sub>Y783/795F</sub> (kindly provided by S. Johansson, The Biomedical Center, Uppsala, Sweden) were cultured in DMEM plus 10&#x00025; FBS &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b056">56</xref>,<xref ref-type="bibr" rid="ppat-0030100-b057">57</xref>&#x0005d;. Puromycin (Sigma-Aldrich, <ext-link ext-link-type="uri" xlink:href="http://www.sigmaaldrich.com/">http://www.sigmaaldrich.com/</ext-link>), at a concentration of 10 &#x003bc;g/ml, was used to maintain the stably transfected GD25 cell lines. The FAK-null mouse embryonic fibroblast cell line (FAK&#x02212;/&#x02212;; ATCC CRL-2644) and the control cell line (FAK&#x0002b;/&#x0002b;; ATCC CRL-2645) were maintained in DMEM plus 10&#x00025; FBS. UTI89, a well-characterized human cystitis isolate, and the recombinant K-12 <named-content content-type="genus-species">E. coli</named-content> strains AAEC185/pSH2 (type 1 pili<sup>&#x0002b;</sup>) and AAEC185/pUT2002 (type 1 pili<sup>&#x0002b;</sup>/<italic>&#x00394;fimH</italic> ), have been described &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b008">8</xref>,<xref ref-type="bibr" rid="ppat-0030100-b009">9</xref>,<xref ref-type="bibr" rid="ppat-0030100-b052">52</xref>&#x0005d;. Targeted deletion of <italic>fimH</italic> in UTI89 was accomplished by lambda Red&#x02013;mediated linear transformation and verified by PCR as well as by yeast and red blood cell agglutination assays &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b097">97</xref>&#x0005d;. These strains were grown at 37 &#x000b0;C in 20 ml static Luria Bertani (LB) broth cultures for 48 h to stimulate expression of type 1 pili. pcDNA4A(&#x003b2;1&#x0005f;V5His6), which encodes the human &#x003b2;1A isoform with N-terminal V5 and 6XHis epitope tags, was generously provided by S. Kuwada (University of Utah, Salt Lake city, Utah, United States) &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b098">98</xref>&#x0005d;. pCMV<sub>zeo</sub>-h&#x003b1;3A, which encodes human &#x003b1;3 integrin, was provided by M. E. Hemler (Harvard Medical School, Boston, Massachusetts, United States) &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b099">99</xref>&#x0005d;.</p><p>For coordinate expression and purification of FimC and FimH, we constructed a dual cistronic plasmid pJLJ200 encoding FimC with a COOH-terminal 6XHisFLAG-tag fusion and wild-type FimH under control of independent T7 promoters. <italic>fimC</italic> and <italic>fimH</italic> were amplified from plasmid pSH2 &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b100">100</xref>&#x0005d; using primers Cfor1 (5&#x02032;-TGATA<underline underline-style="double">CCATGG</underline>TG<underline>AGTAATAAAAACGTCAATG</underline>-3&#x02032;), Crev2&#x0005f;HisFLAGN (5&#x02032;-ACGTT<underline underline-style="double">AAGCTT</underline>ATCCCTTATCGTCGTCATCCTTGTAGTCGTGGTGATGATGGTGATG<underline>TTCCATTACGCCCGTCATTT</underline>-3&#x02032;), Hfor1 (5&#x02032;-TTCAG<underline underline-style="double">CATATG</underline><underline>AAACGAGTTATTACCCTGT</underline>-3&#x02032;), and Hrev1 (5&#x02032;-ACTTACTCGAG<underline>TTATTGATAAACAAAAGTCACGA</underline>-3&#x02032;). The doubly underlined sequences indicate, respectively, NcoI, HindIII, NdeI, and XhoI sites that were introduced for cloning purposes. Singly underlined sequences indicate homology regions to the targeted <italic>fimC</italic> and <italic>fimH</italic> genes. Crev2&#x0005f;HisFLAGN was used to append sequences encoding adjacent 6XHis and FLAG tags at the COOH-terminus of FimC. Amplified <italic>fimC<sub>6XHisFLAG</sub></italic> and <italic>fimH</italic> PCR products were digested using appropriate restriction enzymes and ligated, respectively, into multiple cloning sites 1 and 2 of pETDuet-1 (Novagen, <ext-link ext-link-type="uri" xlink:href="http://www.emdbiosciences.com/html/NVG/home.html">http://www.emdbiosciences.com/html/NVG/home.html</ext-link>) to create pJLJ200. A construct encoding FimC<sub>6XHisFLAG</sub> by itself was designated pJLJ300. For expression of recombinant proteins, the <named-content content-type="genus-species">E. coli</named-content> strain BL21(DE3) (Novagen) encoding isopropyl-1-thio-&#x003b2;-D-galactopyranoside (IPTG)-inducible T7 polymerase was transformed with either pJLJ200 or pJLJ300.</p></sec><sec id="s4b"><title>FimC and FimCH purification.</title><p>BL21(DE3)/pJLJ200 was inoculated 1:100 from an overnight culture into 2 L of LB broth plus 100 ug of ampicillin/ml (Sigma-Aldrich) and grown shaking at 37 &#x000b0;C to a density of OD<sub>600</sub> &#x0223c;0.6. At this point, expression of FimC<sub>6XHisFLAG</sub> and FimH was induced by addition of 1 mM IPTG for 3 h. Bacteria were then pelleted, resuspended in cold 20 mM Tris (pH 8.0)/20&#x00025; sucrose, and lysed on ice by addition of 5 &#x003bc;M EDTA and 75 &#x003bc;g of lysozyme/ml for 30 min. Next, 10 mM MgCl<sub>2</sub> was added and unbroken bacteria and large debris were pelleted at 10,000<italic>g</italic> for 20 min at 4 &#x000b0;C. The supernatant, containing periplasmic proteins, was dialyzed against 20 mM Tris (pH 8.0) and loaded on Ni-NTA agarose columns (Qiagen, <ext-link ext-link-type="uri" xlink:href="http://www.qiagen.com/">http://www.qiagen.com/</ext-link>). The column was washed with 20X column volumes of wash buffer (20 mM Tris &#x0005b;pH 8.0&#x0005d;, 150 mM NaCl, and 20 mM imidazole) prior to elution of FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes using 250 mM imidazole. Complexes were further purified using an anti-FLAG M2 agarose column (Sigma-Aldrich). Bound FimC<sub>6XHisFLAG</sub> and associated FimH were washed with 15X column volumes of Tris-buffered saline (TBS, pH 7.4) prior to elution using 5 mg of FLAG peptide/ml (Sigma-Aldrich). Following the same protocol, FimC<sub>6XHisFLAG</sub> in the absence of FimH was purified from strain BL21(DE3)/pJLJ300. The purity of the recovered recombinant proteins was determined by Western blot analysis and GelCode Blue&#x02013;stained gels (Pierce, <ext-link ext-link-type="uri" xlink:href="http://www.piercenet.com/">http://www.piercenet.com/</ext-link>).</p></sec><sec id="s4c"><title>Overlay assays and identification of candidate receptors.</title><p>The membrane fraction from two confluent T75 flasks of 5637 bladder epithelial cell monolayers was isolated using an established protocol &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b101">101</xref>&#x0005d;. Briefly, cells were recovered by scraping into cold phosphate buffered saline (PBS), pelleted at 600<italic>g</italic> for 5 min, resuspended in 1 ml of HN buffer (5 mM HEPES &#x0005b;pH 7.5&#x0005d;, 0.25 M sucrose) plus protease inhibitors (including 200 &#x003bc;M PMSF and a 1X protease inhibitor cocktail; Roche, <ext-link ext-link-type="uri" xlink:href="http://www.roche.com/">http://www.roche.com/</ext-link>) and Dounce homogenized. Cell debris was removed by centrifugation at 600<italic>g</italic> for 10 min, and membranes in the resultant supernatant were pelleted by spinning at 10,000<italic>g</italic> for 30 min at 4 &#x000b0;C. The membrane pellet was lysed in 110 &#x003bc;l of 2X sample buffer (78 mM Tris &#x0005b;pH 6.8&#x0005d;, 1&#x00025; 2-mercaptoethanol, 0.001&#x00025; bromophenol blue, 10&#x00025; glycerol, 3&#x00025; SDS) and heated for 5 min at 100 &#x000b0;C. Triplicate 20-&#x003bc;l aliquots, along with molecular weight standards in adjacent lanes, were resolved by SDS-PAGE using 12&#x00025; polyacrylamide gels. Proteins from one set of lanes were stained using GelCode Blue while the other two sets were transferred to PVDF membrane and incubated for 20 min at room temperature in blocking buffer (TBS &#x0002b; 0.1&#x00025; Tween-20 &#x0005b;TBS-T, pH 7.4&#x0005d;, 1&#x00025; BSA, and 1&#x00025; powdered milk). Blocked membranes were then incubated for 90 min with 150 ug of purified recombinant FimC<sub>6XHisFLAG</sub> alone or purified FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes in 3 ml of blocking buffer &#x0002b;/&#x02212; 2.5&#x00025; D-mannose. Following 3 &#x000d7; 3-min washes with TBS-T, the membranes were incubated for 45 min with an anti-FLAG monoclonal antibody (diluted 1:1000; Sigma-Aldrich). After a final 30-min incubation with secondary anti-mouse IgG-HRP conjugate (1:10,000; Amersham Biosciences, <ext-link ext-link-type="uri" xlink:href="http://www.gelifesciences.com/">http://www.gelifesciences.com/</ext-link>), blots were washed, developed using SuperSignal West Pico Chemiluminescent Substrate (Pierce), and exposed to CL-XPosure Film (Pierce). Host protein bands that bound purified FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes, as determined by this overlay assay, were excised from the corresponding GelCode Blue&#x02013;stained gel, subjected to in-gel trypsin digestion, and identified using liquid chromatography/mass spectrometry at the University of Utah core facility.</p></sec><sec id="s4d"><title>Integrin immunoprecipitation and glycosidase treatments.</title><p>5637 cells at 80&#x00025; confluency were transfected with pcDNA4A(&#x003b2;1&#x0005f;V5His6) or pCMV<sub>zeo</sub>-h&#x003b1;3A using the LT-1 transfection reagent (Mirus, <ext-link ext-link-type="uri" xlink:href="http://www.mirusbio.com/">http://www.mirusbio.com/</ext-link>). Then, 24 h post-transfection, 5637 monolayers were lysed in TNN buffer (50 mM Tris &#x0005b;pH 7.4&#x0005d;, 150 mM NaCl, 1&#x00025; NP-40, and 1X protease inhibitors) for 30 min on ice. Post-nuclear supernatants were pre-cleared with protein G-coupled agarose beads (Sigma-Aldrich) for 30 min at 4 &#x000b0;C prior to incubation with polyclonal anti-V5 tag (2 &#x003bc;g/ml; Bethyl Laboratories, <ext-link ext-link-type="uri" xlink:href="http://www.bethyl.com/">http://www.bethyl.com/</ext-link>) or rabbit anti&#x02013;&#x003b1;3 integrin antibody (5 &#x003bc;g/ml; Chemicon, <ext-link ext-link-type="uri" xlink:href="http://www.chemicon.com/">http://www.chemicon.com/</ext-link>) for an additional 2 h at 4 &#x000b0;C. Immune complexes were precipitated using protein G-coupled beads and washed 4&#x000d7; with TNN lysis buffer. The beads were then divided into three samples and left untreated or treated with either 100 U of endoglycosidase Hf (EndoHf, 100,000 U/ml; New England Biolabs, <ext-link ext-link-type="uri" xlink:href="http://www.neb.com/">http://www.neb.com/</ext-link>) or 5 U of Peptide: N-glycosidase F (PNGase F, 5,000 U/ml; New England Biolabs) for 60 min at 37 &#x000b0;C. Each sample was further divided in three and resolved by SDS-PAGE before transfer to PVDF membranes. The blots were overlaid with recombinant FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes, FimC<sub>6XHisFLAG</sub>&#x02013;FimH complexes plus 2.5&#x00025; D-mannose, or FimC<sub>6XHisFLAG</sub> alone and probed using anti-FLAG tag antibody as described above. The same blots were subsequently incubated with either polyclonal anti&#x02013;&#x003b2;1 integrin antibody or rabbit anti&#x02013;&#x003b1;3 integrin (both at 1:1000, Chemicon). Following incubations with HRP-tagged secondary antibodies (Amersham Biosciences), blots were washed and developed using SuperSignal West Pico Chemiluminescent Substrate (Pierce). Alternately, blots were incubated with IRDye-labeled secondary antibodies and visualized using an Odyssey Infrared Imaging System (LI-COR Biosciences, <ext-link ext-link-type="uri" xlink:href="http://www.licor.com/">http://www.licor.com/</ext-link>).</p></sec><sec id="s4e"><title>Invasion and cell association assays.</title><p>Bacterial invasion and cell association assays were performed essentially as previously described &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b018">18</xref>,<xref ref-type="bibr" rid="ppat-0030100-b051">51</xref>&#x0005d;. Within 24 h of seeding into 24-well plates, triplicate wells of confluent monolayers of host cells were infected with either UTI89 or AAEC185/pSH2 at a multiplicity of infection (MOI) of 1&#x02013;15 bacteria per host cell. Plates were spun at 600<italic>g</italic> for 5 min to expedite and synchronize bacterial contact with the host cell monolayers prior to a 2-h incubation at 37 &#x000b0;C. For cell association assays, host cells were then washed 4&#x000d7; with PBS<sup>2&#x0002b;</sup> (PBS supplemented with Mg<sup>2&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup>) and lysed in 1 ml of PBS<sup>2&#x0002b;</sup> containing 0.4&#x00025; Triton X-100. For invasion assays, extracellular bacteria were killed following the initial 2-h incubation period by an additional 2-h incubation in medium containing the host membrane-impermeable bacteriocidal agent gentamicin (100 &#x003bc;g/ml; Sigma-Aldrich). Cells were then washed 4&#x000d7; with PBS<sup>2&#x0002b;</sup> and lysed. Bacterial titers in the lysates were determined by serial dilutions and plating on LB agar plates. Except for the antibody blocking experiments, all results from invasion assays were normalized by dividing the number of intracellular bacteria by the total number of cell-associated bacteria &#x0005b;<xref ref-type="bibr" rid="ppat-0030100-b051">51</xref>&#x0005d;. Levels of intracellular and cell-associated bacteria were expressed as percentages relative to control samples, and all assays were repeated three or more times in triplicate. The significance of the observed differences was analyzed using Student's <italic>t</italic>-test (<italic>p</italic> &#x0003c; 0.05 was considered to be significant).</p><p>For the antibody blocking experiments, 5637 bladder cell monolayers in 24-well plates were pre-incubated with purified monoclonal antibodies for 30 min prior to the addition of bacteria. The final concentration of each antibody was 1.5 &#x003bc;g/well. Antibodies against human &#x003b2;1 (6S6), &#x003b2;4 (ASC-3), &#x003b1;2 (P1E6), and &#x003b1;3 (P1B5) integrins were purchased from Chemicon, while anti-human &#x003b1;6 integrin (GoH3) and the &#x003b2;1-activating antibody (P4G11) were obtained from R&#x00026;D Systems (<ext-link ext-link-type="uri" xlink:href="http://www.rndsystems.com/">http://www.rndsystems.com/</ext-link>). The GoH3 antibody was also purchased from Abcam (<ext-link ext-link-type="uri" xlink:href="http://www.abcam.com/">http://www.abcam.com/</ext-link>). To test the role of Src family kinases on bacterial invasion, 5637 bladder cells were pre-incubated with PP1 (20 &#x003bc;M; Biomol, <ext-link ext-link-type="uri" xlink:href="http://www.biomol.com/">http://www.biomol.com/</ext-link>) or PP2 (20 &#x003bc;M; Calbiochem, <ext-link ext-link-type="uri" xlink:href="http://www.emdbiosciences.com/html/CBC/home.html">http://www.emdbiosciences.com/html/CBC/home.html</ext-link>) for 1 h prior to infection. Control cells were treated with only the carrier (DMSO) or with PP3 (20 &#x003bc;M, Calbiochem). None of the inhibitors or DMSO alone had any effect on host cell or bacterial viability during the course of the experiments.</p><p>To knockdown FAK expression prior to invasion and host cell-association assays, 5637 cells were transfected with a FAK-specific siRNA SmartPool using Dharmafect 1 reagent (Dharmacon, <ext-link ext-link-type="uri" xlink:href="http://www.dharmacon.com/">http://www.dharmacon.com/</ext-link>). Control cells were transfected with scrambled siRNA. Invasion and cell association assays were performed 72 h after transfection. In parallel assays, FAK expression was assessed by Western blot analysis of transfected 5637 cell lysates prepared in TNN buffer plus protease inhibitors. Protein concentrations from post-nuclear supernatants were determined using the BCA reagent system (Pierce). Protein (20 &#x003bc;g) from each sample was resolved by SDS-PAGE and transferred to Immobilon-FL PVDF membranes (Millipore, <ext-link ext-link-type="uri" xlink:href="http://www.millipore.com/">http://www.millipore.com/</ext-link>). Following incubations with mouse anti-FAK (1:1000, BD Transduction Laboratories, <ext-link ext-link-type="uri" xlink:href="http://www.bdbiosciences.com/">http://www.bdbiosciences.com/</ext-link>) or mouse anti-actin antibodies (1:400, Abcam), blots were probed using IRDye-labeled secondary antibodies and visualized using an Odyssey Infrared Imaging System (LI-COR Biosciences).</p></sec><sec id="s4f"><title>Flow cytometry analysis.</title><p>The surface expression of &#x003b2;1 integrin by the GD25 cell line and its derivatives was quantified by flow cytometry. Cells (1 &#x000d7; 10<sup>6</sup>) were incubated in PBS/2&#x00025; FBS with a fluorescein isothiocyanate (FITC)-conjugated &#x003b2;1 integrin&#x02013;specific antibody (HM&#x003b2;1&#x02013;1; Serotec, <ext-link ext-link-type="uri" xlink:href="http://www.ab-direct.com/">http://www.ab-direct.com/</ext-link>) or a FITC-labeled isotype control for 20 min on ice. After several washes, samples were assayed by FACScan analysis (Becton Dickinson, <ext-link ext-link-type="uri" xlink:href="http://www.bd.com/">http://www.bd.com/</ext-link>). The mean fluorescence peak channel intensities reflect numbers of surface-localized &#x003b2;1 integrin receptors from HM&#x003b2;1&#x02013;1&#x02013;stained samples. Signals from HM&#x003b2;1&#x02013;1&#x02013;stained GD25 cells were comparable to those seen with samples treated with the isotype control antibody and is considered background. Three independent experiments were performed with similar trends in mean fluorescence intensities observed each time. However, the actual values differed depending on variations during the staining and acquisition setup for each experiment. Therefore, data is presented as the means &#x0002b;/&#x02212; standard deviation from a single representative experiment repeated in triplicate.</p></sec><sec id="s4g"><title>Immunofluorescence microscopy.</title><p>Thirty minutes post-infection with wild-type UTI89, <italic>&#x00394;fimH</italic> UTI89, AAEC185/pSH2, or AAEC185/pUT2002 (MOI &#x0003d; 1&#x02013;15), 5637 cells grown on 12-mm-diameter glass coverslips were washed with cold PBS<sup>2&#x0002b;</sup> and fixed in acetone for 3 min at &#x02212;20 &#x000b0;C. Samples were then rinsed 3 &#x000d7; 5 min with PBS, incubated for 30 min in blocking buffer (3&#x00025; BSA/1&#x00025; milk/PBS), and stained using rat anti-human &#x003b2;1 integrin (AIIB2, 1:100; Developmental Studies Hybridoma Bank at the University of Iowa, <ext-link ext-link-type="uri" xlink:href="http://dshb.biology.uiowa.edu/">http://dshb.biology.uiowa.edu/</ext-link>), P1B5 (1:500; Chemicon), or mouse anti-&#x003b1;3&#x003b2;1 (1:250; Chemicon) and rabbit anti&#x02013;<named-content content-type="genus-species">E. coli</named-content> (1:500; BioDesign, <ext-link ext-link-type="uri" xlink:href="http://meridianlifescience.com/">http://meridianlifescience.com/</ext-link>) primary antibodies along with appropriate Alexa Fluor-conjugated secondary antibodies (1:500; Molecular Probes/Invitrogen, <ext-link ext-link-type="uri" xlink:href="http://probes.invitrogen.com/">http://probes.invitrogen.com/</ext-link>). Alexa568-conjugated phalloidin (1:40; Molecular Probes) was used to label F-actin. Following final washes in PBS, samples were mounted onto slides using FluorSave reagent (Calbiochem/EMD Biosciences) and viewed using an Olympus IX70 FV300 confocal microscope equipped with a 60&#x000d7; oil immersion objective (Olympus PlanApo NA 1.42 Oil immersion TIRFM), and argon and helium-neon (HeNe) lasers providing excitation energy at 488, 543, and 633 nm. Images were captured at the University of Utah School of Medicine Cell Imaging Facility using Olympus Fluoview software and subsequently analyzed using Volocity software (Improvision, <ext-link ext-link-type="uri" xlink:href="http://www.improvision.com/">http://www.improvision.com/</ext-link>).</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><sec id="s5a"><title>Accession Numbers</title><p>The GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/">http://www.ncbi.nlm.nih.gov/Genbank/</ext-link>) accession numbers for the proteins discussed in this paper are &#x003b1;3 integrin (NP&#x0005f;002195), &#x003b2;1 integrin (NP&#x0005f;034708, NP&#x0005f;596867), FAK (AAA37592, AAA58469), FimC (P31697), FimH (AAX11338), and Src (NP&#x0005f;005408).</p></sec></sec></body><back><ack><p>We are grateful to S. Kuwada for pcDNA4A(&#x003b2;1&#x0005f;V5His6), M. E. Hemler and C. M. DiPersio for providing pCMV<sub>zeo</sub>-h&#x003b1;3A, and S. Johansson for the GD25 cell lines. We also want thank T. Wiles and E. S. Slechta for constructing <italic>&#x00394;fimH</italic> UTI89, and other members of the Mulvey lab for many helpful discussions and suggestions.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>ECM</term><def><p>extracellular matrix</p></def></def-item><def-item><term>FAK</term><def><p>focal adhesion kinase</p></def></def-item><def-item><term>PI 3-kinase</term><def><p>phosphoinositide 3-kinase</p></def></def-item><def-item><term>PVDF</term><def><p>polyvinylidene fluoride</p></def></def-item><def-item><term>siRNA</term><def><p>small interfering RNA</p></def></def-item><def-item><term>UP1a</term><def><p>uroplakin 1a</p></def></def-item><def-item><term>UPEC</term><def><p>uropathogenic Escherichia coli</p></def></def-item><def-item><term>UTI</term><def><p>urinary tract infection</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ppat-0030100-b001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bower</surname><given-names>JM</given-names></name><name><surname>Eto</surname><given-names>DS</given-names></name><name><surname>Mulvey</surname><given-names>MA</given-names></name></person-group><year>2005</year><article-title>Covert operations of uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content> within the urinary tract</article-title><source>Traffic</source><volume>6</volume><fpage>18</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">15569242</pub-id></citation></ref><ref id="ppat-0030100-b002"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>P</given-names></name></person-group><year>2003</year><article-title>Epidemiology of urinary tract infections: Transmission and risk factors, incidence, and costs</article-title><source>Infect Dis Clin North Am</source><volume>17</volume><fpage>227</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">12848468</pub-id></citation></ref><ref id="ppat-0030100-b003"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Barlow</surname><given-names>R</given-names></name><name><surname>D'Arcy</surname><given-names>H</given-names></name><name><surname>Gillespie</surname><given-names>B</given-names></name><name><surname>Sobel</surname><given-names>JD</given-names></name></person-group><year>2000</year><article-title>Urinary tract infection: Self-reported incidence and associated costs</article-title><source>Ann Epidemiol</source><volume>10</volume><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">11118930</pub-id></citation></ref><ref id="ppat-0030100-b004"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ronald</surname><given-names>A</given-names></name></person-group><year>2002</year><article-title>The etiology of urinary tract infection: Traditional and emerging pathogens</article-title><source>Am J Med</source><volume>113</volume><issue>Suppl 1A</issue><fpage>14S</fpage><lpage>19S</lpage><pub-id pub-id-type="pmid">12113867</pub-id></citation></ref><ref id="ppat-0030100-b005"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foxman</surname><given-names>B</given-names></name></person-group><year>1990</year><article-title>Recurring urinary tract infection: Incidence and risk factors</article-title><source>Am J Public Health</source><volume>80</volume><fpage>331</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">2305919</pub-id></citation></ref><ref id="ppat-0030100-b006"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Justice</surname><given-names>SS</given-names></name><name><surname>Hung</surname><given-names>C</given-names></name><name><surname>Theriot</surname><given-names>JA</given-names></name><name><surname>Fletcher</surname><given-names>DA</given-names></name><name><surname>Anderson</surname><given-names>GG</given-names></name><etal/></person-group><year>2004</year><article-title>Differentiation and developmental pathways of uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content> in urinary tract pathogenesis</article-title><source>Proc Natl Acad Sci U S A</source><volume>101</volume><fpage>1333</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">14739341</pub-id></citation></ref><ref id="ppat-0030100-b007"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schilling</surname><given-names>JD</given-names></name><name><surname>Lorenz</surname><given-names>RG</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><year>2002</year><article-title>Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Infect Immun</source><volume>70</volume><fpage>7042</fpage><lpage>7049</lpage><pub-id pub-id-type="pmid">12438384</pub-id></citation></ref><ref id="ppat-0030100-b008"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulvey</surname><given-names>MA</given-names></name><name><surname>Lopez-Boado</surname><given-names>YS</given-names></name><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Roth</surname><given-names>R</given-names></name><name><surname>Parks</surname><given-names>WC</given-names></name><etal/></person-group><year>1998</year><article-title>Induction and evasion of host defenses by type 1-piliated uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Science</source><volume>282</volume><fpage>1494</fpage><lpage>1497</lpage><pub-id pub-id-type="pmid">9822381</pub-id></citation></ref><ref id="ppat-0030100-b009"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulvey</surname><given-names>MA</given-names></name><name><surname>Schilling</surname><given-names>JD</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><year>2001</year><article-title>Establishment of a persistent <named-content content-type="genus-species">Escherichia coli</named-content> reservoir during the acute phase of a bladder infection</article-title><source>Infect Immun</source><volume>69</volume><fpage>4572</fpage><lpage>4579</lpage><pub-id pub-id-type="pmid">11402001</pub-id></citation></ref><ref id="ppat-0030100-b010"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eto</surname><given-names>DS</given-names></name><name><surname>Sundsbak</surname><given-names>JL</given-names></name><name><surname>Mulvey</surname><given-names>MA</given-names></name></person-group><year>2006</year><article-title>Actin-gated intracellular growth and resurgence of uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Cell Microbiol</source><volume>8</volume><fpage>704</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">16548895</pub-id></citation></ref><ref id="ppat-0030100-b011"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hvidberg</surname><given-names>H</given-names></name><name><surname>Struve</surname><given-names>C</given-names></name><name><surname>Krogfelt</surname><given-names>KA</given-names></name><name><surname>Christensen</surname><given-names>N</given-names></name><name><surname>Rasmussen</surname><given-names>SN</given-names></name><etal/></person-group><year>2000</year><article-title>Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies</article-title><source>Antimicrob Agents Chemother</source><volume>44</volume><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">10602738</pub-id></citation></ref><ref id="ppat-0030100-b012"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerrn</surname><given-names>MB</given-names></name><name><surname>Struve</surname><given-names>C</given-names></name><name><surname>Blom</surname><given-names>J</given-names></name><name><surname>Frimodt-Moller</surname><given-names>N</given-names></name><name><surname>Krogfelt</surname><given-names>KA</given-names></name></person-group><year>2005</year><article-title>Intracellular persistence of <named-content content-type="genus-species">Escherichia coli</named-content> in urinary bladders from mecillinam-treated mice</article-title><source>J Antimicrob Chemother</source><volume>55</volume><fpage>383</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">15681580</pub-id></citation></ref><ref id="ppat-0030100-b013"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulvey</surname><given-names>MA</given-names></name><name><surname>Schilling</surname><given-names>JD</given-names></name><name><surname>Martinez</surname><given-names>JJ</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><year>2000</year><article-title>Bad bugs and beleaguered bladders: Interplay between uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content> and innate host defenses</article-title><source>Proc Natl Acad Sci U S A</source><volume>97</volume><fpage>8829</fpage><lpage>8835</lpage><pub-id pub-id-type="pmid">10922042</pub-id></citation></ref><ref id="ppat-0030100-b014"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulvey</surname><given-names>MA</given-names></name></person-group><year>2002</year><article-title>Adhesion and entry of uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Cell Microbiol</source><volume>4</volume><fpage>257</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">12027955</pub-id></citation></ref><ref id="ppat-0030100-b015"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doye</surname><given-names>A</given-names></name><name><surname>Mettouchi</surname><given-names>A</given-names></name><name><surname>Bossis</surname><given-names>G</given-names></name><name><surname>Clement</surname><given-names>R</given-names></name><name><surname>Buisson-Touati</surname><given-names>C</given-names></name><etal/></person-group><year>2002</year><article-title>CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion</article-title><source>Cell</source><volume>111</volume><fpage>553</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">12437928</pub-id></citation></ref><ref id="ppat-0030100-b016"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Feito</surname><given-names>MJ</given-names></name><name><surname>Sacks</surname><given-names>SH</given-names></name><name><surname>Sheerin</surname><given-names>NS</given-names></name></person-group><year>2006</year><article-title>CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>J Immunol</source><volume>177</volume><fpage>2543</fpage><lpage>2551</lpage><pub-id pub-id-type="pmid">16888016</pub-id></citation></ref><ref id="ppat-0030100-b017"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Springall</surname><given-names>T</given-names></name><name><surname>Sheerin</surname><given-names>NS</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Holers</surname><given-names>VM</given-names></name><name><surname>Wan</surname><given-names>H</given-names></name><etal/></person-group><year>2001</year><article-title>Epithelial secretion of C3 promotes colonization of the upper urinary tract by <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Nat Med</source><volume>7</volume><fpage>801</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">11433344</pub-id></citation></ref><ref id="ppat-0030100-b018"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>JJ</given-names></name><name><surname>Mulvey</surname><given-names>MA</given-names></name><name><surname>Schilling</surname><given-names>JD</given-names></name><name><surname>Pinkner</surname><given-names>JS</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><year>2000</year><article-title>Type 1 pilus-mediated bacterial invasion of bladder epithelial cells</article-title><source>EMBO J</source><volume>19</volume><fpage>2803</fpage><lpage>2812</lpage><pub-id pub-id-type="pmid">10856226</pub-id></citation></ref><ref id="ppat-0030100-b019"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langermann</surname><given-names>S</given-names></name><name><surname>Palaszynski</surname><given-names>S</given-names></name><name><surname>Barnhart</surname><given-names>M</given-names></name><name><surname>Auguste</surname><given-names>G</given-names></name><name><surname>Pinkner</surname><given-names>JS</given-names></name><etal/></person-group><year>1997</year><article-title>Prevention of mucosal <named-content content-type="genus-species">Escherichia coli</named-content> infection by FimH-adhesin-based systemic vaccination &#x0005b;see comments&#x0005d;</article-title><source>Science</source><volume>276</volume><fpage>607</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">9110982</pub-id></citation></ref><ref id="ppat-0030100-b020"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brinton</surname><given-names>CC</given-names></name></person-group><year>1959</year><article-title>Non-flagellar appendages of bacteria</article-title><source>Nature</source><volume>183</volume><fpage>782</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">13644195</pub-id></citation></ref><ref id="ppat-0030100-b021"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buchanan</surname><given-names>K</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name><name><surname>Hull</surname><given-names>RA</given-names></name><name><surname>Hull</surname><given-names>SI</given-names></name></person-group><year>1985</year><article-title>Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili</article-title><source>J Bacteriol</source><volume>162</volume><fpage>799</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">2859271</pub-id></citation></ref><ref id="ppat-0030100-b022"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>PW</given-names></name><name><surname>Orndorff</surname><given-names>PE</given-names></name></person-group><year>1992</year><article-title>Lesions in two <named-content content-type="genus-species">Escherichia coli</named-content> type 1 pilus genes alter pilus number and length without affecting receptor binding</article-title><source>J Bacteriol</source><volume>174</volume><fpage>5923</fpage><lpage>5935</lpage><pub-id pub-id-type="pmid">1355769</pub-id></citation></ref><ref id="ppat-0030100-b023"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>CH</given-names></name><name><surname>Pinkner</surname><given-names>JS</given-names></name><name><surname>Roth</surname><given-names>R</given-names></name><name><surname>Heuser</surname><given-names>J</given-names></name><name><surname>Nicholes</surname><given-names>AV</given-names></name><etal/></person-group><year>1995</year><article-title>FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae</article-title><source>Proc Natl Acad Sci U S A</source><volume>92</volume><fpage>2081</fpage><lpage>2085</lpage><pub-id pub-id-type="pmid">7892228</pub-id></citation></ref><ref id="ppat-0030100-b024"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Connell</surname><given-names>H</given-names></name><name><surname>Agace</surname><given-names>W</given-names></name><name><surname>Klemm</surname><given-names>P</given-names></name><name><surname>Schembri</surname><given-names>M</given-names></name><name><surname>Marild</surname><given-names>S</given-names></name><etal/></person-group><year>1996</year><article-title>Type 1 fimbrial expression enhances <named-content content-type="genus-species">Escherichia coli</named-content> virulence for the urinary tract</article-title><source>Proc Natl Acad Sci USA</source><volume>93</volume><fpage>9827</fpage><lpage>9832</lpage><pub-id pub-id-type="pmid">8790416</pub-id></citation></ref><ref id="ppat-0030100-b025"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bahrani-Mougeot</surname><given-names>FK</given-names></name><name><surname>Buckles</surname><given-names>EL</given-names></name><name><surname>Lockatell</surname><given-names>CV</given-names></name><name><surname>Hebel</surname><given-names>JR</given-names></name><name><surname>Johnson</surname><given-names>DE</given-names></name><etal/></person-group><year>2002</year><article-title>Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content> virulence determinants in the murine urinary tract</article-title><source>Mol Microbiol</source><volume>45</volume><fpage>1079</fpage><lpage>1093</lpage><pub-id pub-id-type="pmid">12180926</pub-id></citation></ref><ref id="ppat-0030100-b026"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>CS</given-names></name><name><surname>Bouckaert</surname><given-names>J</given-names></name><name><surname>Hung</surname><given-names>D</given-names></name><name><surname>Pinkner</surname><given-names>J</given-names></name><name><surname>Widberg</surname><given-names>C</given-names></name><etal/></person-group><year>2002</year><article-title>Structural basis of tropism of <named-content content-type="genus-species">Escherichia coli</named-content> to the bladder during urinary tract infection</article-title><source>Mol Microbiol</source><volume>44</volume><fpage>903</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">12010488</pub-id></citation></ref><ref id="ppat-0030100-b027"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>GG</given-names></name><name><surname>Palermo</surname><given-names>JJ</given-names></name><name><surname>Schilling</surname><given-names>JD</given-names></name><name><surname>Roth</surname><given-names>R</given-names></name><name><surname>Heuser</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Intracellular bacterial biofilm-like pods in urinary tract infections</article-title><source>Science</source><volume>301</volume><fpage>105</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">12843396</pub-id></citation></ref><ref id="ppat-0030100-b028"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Apodaca</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>The uroepithelium: Not just a passive barrier</article-title><source>Traffic</source><volume>5</volume><fpage>117</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">15086788</pub-id></citation></ref><ref id="ppat-0030100-b029"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>JJ</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><year>2002</year><article-title>Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Cell Microbiol</source><volume>4</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">11856170</pub-id></citation></ref><ref id="ppat-0030100-b030"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>MJ</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Shin</surname><given-names>JS</given-names></name><name><surname>Carson</surname><given-names>JL</given-names></name><name><surname>Abraham</surname><given-names>SN</given-names></name></person-group><year>2004</year><article-title>Bacterial penetration of bladder epithelium through lipid rafts</article-title><source>J Biol Chem</source><volume>279</volume><fpage>18944</fpage><lpage>18951</lpage><pub-id pub-id-type="pmid">14976212</pub-id></citation></ref><ref id="ppat-0030100-b031"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>WJ</given-names></name><name><surname>Reznikoff</surname><given-names>CA</given-names></name><name><surname>Oberley</surname><given-names>TD</given-names></name><name><surname>Uehling</surname><given-names>DT</given-names></name></person-group><year>1990</year><article-title>Adherence of uropathogenic <named-content content-type="genus-species">E. coli</named-content> to differentiated human uroepithelial cells grown in vitro</article-title><source>J Urol</source><volume>143</volume><fpage>146</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">2104636</pub-id></citation></ref><ref id="ppat-0030100-b032"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sokurenko</surname><given-names>EV</given-names></name><name><surname>Courtney</surname><given-names>HS</given-names></name><name><surname>Abraham</surname><given-names>SN</given-names></name><name><surname>Klemm</surname><given-names>P</given-names></name><name><surname>Hasty</surname><given-names>DL</given-names></name></person-group><year>1992</year><article-title>Functional heterogeneity of type 1 fimbriae of <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Infect Immun</source><volume>60</volume><fpage>4709</fpage><lpage>4719</lpage><pub-id pub-id-type="pmid">1356930</pub-id></citation></ref><ref id="ppat-0030100-b033"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pouttu</surname><given-names>R</given-names></name><name><surname>Puustinen</surname><given-names>T</given-names></name><name><surname>Virkola</surname><given-names>R</given-names></name><name><surname>Hacker</surname><given-names>J</given-names></name><name><surname>Klemm</surname><given-names>P</given-names></name><etal/></person-group><year>1999</year><article-title>Amino acid residue Ala-62 in the FimH fimbrial adhesin is critical for the adhesiveness of meningitis-associated <named-content content-type="genus-species">Escherichia coli</named-content> to collagens</article-title><source>Mol Microbiol</source><volume>31</volume><fpage>1747</fpage><lpage>1757</lpage><pub-id pub-id-type="pmid">10209747</pub-id></citation></ref><ref id="ppat-0030100-b034"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kukkonen</surname><given-names>M</given-names></name><name><surname>Raunio</surname><given-names>T</given-names></name><name><surname>Virkola</surname><given-names>R</given-names></name><name><surname>Lahteenmaki</surname><given-names>K</given-names></name><name><surname>Makela</surname><given-names>PH</given-names></name><etal/></person-group><year>1993</year><article-title>Basement membrane carbohydrate as a target for bacterial adhesion: binding of type 1 fimbriae of <named-content content-type="genus-species">Salmonella enterica</named-content> and E<italic>scherichia coli</italic> to laminin</article-title><source>Molecular Microbiology</source><volume>7</volume><fpage>229</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">8095317</pub-id></citation></ref><ref id="ppat-0030100-b035"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leusch</surname><given-names>HG</given-names></name><name><surname>Drzeniek</surname><given-names>Z</given-names></name><name><surname>Markos-Pusztai</surname><given-names>Z</given-names></name><name><surname>Wagener</surname><given-names>C</given-names></name></person-group><year>1991</year><article-title>Binding of <named-content content-type="genus-species">Escherichia coli</named-content> and Salmonella strains to members of the carcinoembryonic antigen family: Differential binding inhibition by aromatic alpha-glycosides of mannose</article-title><source>Infect Immun</source><volume>59</volume><fpage>2051</fpage><lpage>2057</lpage><pub-id pub-id-type="pmid">1674739</pub-id></citation></ref><ref id="ppat-0030100-b036"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauter</surname><given-names>SL</given-names></name><name><surname>Rutherfurd</surname><given-names>SM</given-names></name><name><surname>Wagener</surname><given-names>C</given-names></name><name><surname>Shiveley</surname><given-names>JE</given-names></name><name><surname>Hefta</surname><given-names>SA</given-names></name></person-group><year>1991</year><article-title>Binding of nonspecific crossreacting antigen, a granulocyte membrane glycoprotein, to <named-content content-type="genus-species">Escherichia coli</named-content> expressing type 1 fimbriae</article-title><source>Infect Immun</source><volume>59</volume><fpage>2485</fpage><lpage>2493</lpage><pub-id pub-id-type="pmid">1675630</pub-id></citation></ref><ref id="ppat-0030100-b037"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname><given-names>J</given-names></name><name><surname>Pu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>ZT</given-names></name><name><surname>Hasty</surname><given-names>DL</given-names></name><name><surname>Wu</surname><given-names>XR</given-names></name></person-group><year>2001</year><article-title>Tamm-Horsfall protein binds to type 1 fimbriated <named-content content-type="genus-species">Escherichia coli</named-content> and prevents <named-content content-type="genus-species">E. coli</named-content> from binding to uroplakin Ia and Ib receptors</article-title><source>J Biol Chem</source><volume>276</volume><fpage>9924</fpage><lpage>9930</lpage><pub-id pub-id-type="pmid">11134021</pub-id></citation></ref><ref id="ppat-0030100-b038"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>NA</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name></person-group><year>2007</year><article-title>FimH-mediated <named-content content-type="genus-species">Escherichia coli</named-content> K1 invasion of human brain microvascular endothelial cells</article-title><source>Cell Microbiol</source><volume>9</volume><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">17222190</pub-id></citation></ref><ref id="ppat-0030100-b039"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baorto</surname><given-names>DM</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Malaviya</surname><given-names>R</given-names></name><name><surname>Dustin</surname><given-names>ML</given-names></name><name><surname>van der Merwe</surname><given-names>A</given-names></name><etal/></person-group><year>1997</year><article-title>Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic</article-title><source>Nature</source><volume>389</volume><fpage>636</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">9335508</pub-id></citation></ref><ref id="ppat-0030100-b040"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gbarah</surname><given-names>A</given-names></name><name><surname>Gahmberg</surname><given-names>CG</given-names></name><name><surname>Ofek</surname><given-names>I</given-names></name><name><surname>Jacobi</surname><given-names>U</given-names></name><name><surname>Sharon</surname><given-names>N</given-names></name></person-group><year>1991</year><article-title>Identification of the leukocyte adhesion molecules CD11/CD18 as receptors for type 1 fimbriated (mannose specific) <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>Infect Immun</source><volume>59</volume><fpage>4524</fpage><lpage>4530</lpage><pub-id pub-id-type="pmid">1682263</pub-id></citation></ref><ref id="ppat-0030100-b041"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Mo</surname><given-names>WJ</given-names></name><name><surname>Sebbel</surname><given-names>P</given-names></name><name><surname>Min</surname><given-names>G</given-names></name><name><surname>Neubert</surname><given-names>TA</given-names></name><etal/></person-group><year>2001</year><article-title>Uroplakin Ia is the urothelial receptor for uropathogenic <italic>Escherichia coli:</italic> Evidence from in vitro FimH binding</article-title><source>J Cell Sci</source><volume>114</volume><fpage>4095</fpage><lpage>4103</lpage><pub-id pub-id-type="pmid">11739641</pub-id></citation></ref><ref id="ppat-0030100-b042"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname><given-names>FG</given-names></name><name><surname>Mulvey</surname><given-names>MA</given-names></name><name><surname>Schilling</surname><given-names>JD</given-names></name><name><surname>Martinez</surname><given-names>JJ</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><year>2000</year><article-title>Bacterial pili: Molecular mechanisms of pathogenesis</article-title><source>Curr Opin Microbiol</source><volume>3</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">10679419</pub-id></citation></ref><ref id="ppat-0030100-b043"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnaout</surname><given-names>MA</given-names></name><name><surname>Mahalingam</surname><given-names>B</given-names></name><name><surname>Xiong</surname><given-names>JP</given-names></name></person-group><year>2005</year><article-title>Integrin structure, allostery, and bidirectional signaling</article-title><source>Annu Rev Cell Dev Biol</source><volume>21</volume><fpage>381</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">16212500</pub-id></citation></ref><ref id="ppat-0030100-b044"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guignot</surname><given-names>J</given-names></name><name><surname>Bernet-Camard</surname><given-names>MF</given-names></name><name><surname>Pous</surname><given-names>C</given-names></name><name><surname>Plancon</surname><given-names>L</given-names></name><name><surname>Le Bouguenec</surname><given-names>C</given-names></name><etal/></person-group><year>2001</year><article-title>Polarized entry of uropathogenic Afa/Dr diffusely adhering <named-content content-type="genus-species">Escherichia coli</named-content> strain IH11128 into human epithelial cells: Evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules</article-title><source>Infect Immun</source><volume>69</volume><fpage>1856</fpage><lpage>1868</lpage><pub-id pub-id-type="pmid">11179364</pub-id></citation></ref><ref id="ppat-0030100-b045"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scibelli</surname><given-names>A</given-names></name><name><surname>Roperto</surname><given-names>S</given-names></name><name><surname>Manna</surname><given-names>L</given-names></name><name><surname>Pavone</surname><given-names>LM</given-names></name><name><surname>Tafuri</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Engagement of integrins as a cellular route of invasion by bacterial pathogens</article-title><source>Vet J</source><volume>173</volume><fpage>482</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">16546423</pub-id></citation></ref><ref id="ppat-0030100-b046"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>DY</given-names></name><name><surname>Huong</surname><given-names>SM</given-names></name><name><surname>Huang</surname><given-names>ES</given-names></name></person-group><year>2005</year><article-title>Integrin alphavbeta3 is a coreceptor for human cytomegalovirus</article-title><source>Nat Med</source><volume>11</volume><fpage>515</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">15834425</pub-id></citation></ref><ref id="ppat-0030100-b047"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cue</surname><given-names>D</given-names></name><name><surname>Lam</surname><given-names>H</given-names></name><name><surname>Cleary</surname><given-names>PP</given-names></name></person-group><year>2001</year><article-title>Genetic dissection of the <named-content content-type="genus-species">Streptococcus pyogenes</named-content> M1 protein: Regions involved in fibronectin binding and intracellular invasion</article-title><source>Microb Pathog</source><volume>31</volume><fpage>231</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">11710843</pub-id></citation></ref><ref id="ppat-0030100-b048"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isberg</surname><given-names>RR</given-names></name><name><surname>Leong</surname><given-names>JM</given-names></name></person-group><year>1990</year><article-title>Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells</article-title><source>Cell</source><volume>60</volume><fpage>861</fpage><lpage>871</lpage><pub-id pub-id-type="pmid">2311122</pub-id></citation></ref><ref id="ppat-0030100-b049"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tran Van Nhieu</surname><given-names>G</given-names></name><name><surname>Isberg</surname><given-names>RR</given-names></name></person-group><year>1993</year><article-title>Bacterial internalization mediated by beta 1 chain integrins is determined by ligand affinity and receptor density</article-title><source>EMBO J</source><volume>12</volume><fpage>1887</fpage><lpage>1895</lpage><pub-id pub-id-type="pmid">8491181</pub-id></citation></ref><ref id="ppat-0030100-b050"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plancon</surname><given-names>L</given-names></name><name><surname>Du Merle</surname><given-names>L</given-names></name><name><surname>Le Friec</surname><given-names>S</given-names></name><name><surname>Gounon</surname><given-names>P</given-names></name><name><surname>Jouve</surname><given-names>M</given-names></name><etal/></person-group><year>2003</year><article-title>Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic <named-content content-type="genus-species">Escherichia coli</named-content> strains</article-title><source>Cell Microbiol</source><volume>5</volume><fpage>681</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">12969374</pub-id></citation></ref><ref id="ppat-0030100-b051"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elsinghorst</surname><given-names>EA</given-names></name></person-group><year>1994</year><article-title>Measurement of invasion by gentamicin resistance</article-title><source>Methods Enzymol</source><volume>236</volume><fpage>405</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">7968625</pub-id></citation></ref><ref id="ppat-0030100-b052"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SL</given-names></name><name><surname>Hung</surname><given-names>CS</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Reigstad</surname><given-names>CS</given-names></name><name><surname>Magrini</surname><given-names>V</given-names></name><etal/></person-group><year>2006</year><article-title>Identification of genes subject to positive selection in uropathogenic strains of <italic>Escherichia coli:</italic> A comparative genomics approach</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>5977</fpage><lpage>5982</lpage><pub-id pub-id-type="pmid">16585510</pub-id></citation></ref><ref id="ppat-0030100-b053"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>SN</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Dale</surname><given-names>JB</given-names></name><name><surname>Beachey</surname><given-names>EH</given-names></name></person-group><year>1988</year><article-title>Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobactericeae</article-title><source>Nature</source><volume>336</volume><fpage>682</fpage><lpage>684</lpage><pub-id pub-id-type="pmid">2904657</pub-id></citation></ref><ref id="ppat-0030100-b054"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klemm</surname><given-names>P</given-names></name><name><surname>Krogfelt</surname><given-names>KA</given-names></name><name><surname>Hedegaard</surname><given-names>L</given-names></name><name><surname>Christiansen</surname><given-names>G</given-names></name></person-group><year>1990</year><article-title>The major subunit of <named-content content-type="genus-species">Escherichia coli</named-content> type 1 fimbriae is not required for D-mannose-specific adhesion</article-title><source>Mol Microbiol</source><volume>4</volume><fpage>553</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">1972261</pub-id></citation></ref><ref id="ppat-0030100-b055"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krogfelt</surname><given-names>KA</given-names></name><name><surname>Bergmans</surname><given-names>H</given-names></name><name><surname>Klemm</surname><given-names>P</given-names></name></person-group><year>1990</year><article-title>Direct evidence that the FimH protein is the mannose specific adhesin of <named-content content-type="genus-species">Escherichia coli</named-content> type 1 fimbriae</article-title><source>Infect Immun</source><volume>58</volume><fpage>1995</fpage><lpage>1999</lpage><pub-id pub-id-type="pmid">1971261</pub-id></citation></ref><ref id="ppat-0030100-b056"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fassler</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name></person-group><year>1995</year><article-title>Consequences of lack of beta 1 integrin gene expression in mice</article-title><source>Genes Dev</source><volume>9</volume><fpage>1896</fpage><lpage>1908</lpage><pub-id pub-id-type="pmid">7544313</pub-id></citation></ref><ref id="ppat-0030100-b057"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wennerberg</surname><given-names>K</given-names></name><name><surname>Lohikangas</surname><given-names>L</given-names></name><name><surname>Gullberg</surname><given-names>D</given-names></name><name><surname>Pfaff</surname><given-names>M</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><etal/></person-group><year>1996</year><article-title>Beta 1 integrin-dependent and -independent polymerization of fibronectin</article-title><source>J Cell Biol</source><volume>132</volume><fpage>227</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">8567726</pub-id></citation></ref><ref id="ppat-0030100-b058"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wennerberg</surname><given-names>K</given-names></name><name><surname>Fassler</surname><given-names>R</given-names></name><name><surname>Warmegard</surname><given-names>B</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name></person-group><year>1998</year><article-title>Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin beta1A. Requirement for threonines 788&#x02013;789 in receptor activation</article-title><source>J Cell Sci</source><volume>111</volume><issue>(Part 8)</issue><fpage>1117</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">9512507</pub-id></citation></ref><ref id="ppat-0030100-b059"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Fassler</surname><given-names>R</given-names></name><name><surname>Mosher</surname><given-names>DF</given-names></name></person-group><year>1998</year><article-title>Modulation of beta1A integrin functions by tyrosine residues in the beta1 cytoplasmic domain</article-title><source>J Cell Biol</source><volume>141</volume><fpage>527</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">9548729</pub-id></citation></ref><ref id="ppat-0030100-b060"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulrooney</surname><given-names>JP</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Grabel</surname><given-names>LB</given-names></name></person-group><year>2001</year><article-title>Serine 785 phosphorylation of the beta1 cytoplasmic domain modulates beta1A-integrin-dependent functions</article-title><source>J Cell Sci</source><volume>114</volume><fpage>2525</fpage><lpage>2533</lpage><pub-id pub-id-type="pmid">11559760</pub-id></citation></ref><ref id="ppat-0030100-b061"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wennerberg</surname><given-names>K</given-names></name><name><surname>Armulik</surname><given-names>A</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Karlsson</surname><given-names>M</given-names></name><name><surname>Fassler</surname><given-names>R</given-names></name><etal/></person-group><year>2000</year><article-title>The cytoplasmic tyrosines of integrin subunit beta1 are involved in focal adhesion kinase activation</article-title><source>Mol Cell Biol</source><volume>20</volume><fpage>5758</fpage><lpage>5765</lpage><pub-id pub-id-type="pmid">10891511</pub-id></citation></ref><ref id="ppat-0030100-b062"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>GW</given-names></name><name><surname>Carragher</surname><given-names>NO</given-names></name><name><surname>Avizienyte</surname><given-names>E</given-names></name><name><surname>Evans</surname><given-names>J</given-names></name><name><surname>Brunton</surname><given-names>VG</given-names></name><etal/></person-group><year>2005</year><article-title>The role of focal-adhesion kinase in cancer&#x02014;A new therapeutic opportunity</article-title><source>Nat Rev Cancer</source><volume>5</volume><fpage>505</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">16069815</pub-id></citation></ref><ref id="ppat-0030100-b063"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>SK</given-names></name><name><surname>Hanson</surname><given-names>DA</given-names></name><name><surname>Schlaepfer</surname><given-names>DD</given-names></name></person-group><year>2005</year><article-title>Focal adhesion kinase: In command and control of cell motility</article-title><source>Nat Rev Mol Cell Biol</source><volume>6</volume><fpage>56</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">15688067</pub-id></citation></ref><ref id="ppat-0030100-b064"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanke</surname><given-names>JH</given-names></name><name><surname>Gardner</surname><given-names>JP</given-names></name><name><surname>Dow</surname><given-names>RL</given-names></name><name><surname>Changelian</surname><given-names>PS</given-names></name><name><surname>Brissette</surname><given-names>WH</given-names></name><etal/></person-group><year>1996</year><article-title>Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation</article-title><source>J Biol Chem</source><volume>271</volume><fpage>695</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">8557675</pub-id></citation></ref><ref id="ppat-0030100-b065"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ilic</surname><given-names>D</given-names></name><name><surname>Furuta</surname><given-names>Y</given-names></name><name><surname>Kanazawa</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Sobue</surname><given-names>K</given-names></name><etal/></person-group><year>1995</year><article-title>Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice</article-title><source>Nature</source><volume>377</volume><fpage>539</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">7566154</pub-id></citation></ref><ref id="ppat-0030100-b066"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elices</surname><given-names>MJ</given-names></name><name><surname>Urry</surname><given-names>LA</given-names></name><name><surname>Hemler</surname><given-names>ME</given-names></name></person-group><year>1991</year><article-title>Receptor functions for the integrin VLA-3: Fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations</article-title><source>J Cell Biol</source><volume>112</volume><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">1986004</pub-id></citation></ref><ref id="ppat-0030100-b067"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouckaert</surname><given-names>J</given-names></name><name><surname>Mackenzie</surname><given-names>J</given-names></name><name><surname>de Paz</surname><given-names>JL</given-names></name><name><surname>Chipwaza</surname><given-names>B</given-names></name><name><surname>Choudhury</surname><given-names>D</given-names></name><etal/></person-group><year>2006</year><article-title>The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of <named-content content-type="genus-species">Escherichia coli</named-content> pathotypes</article-title><source>Mol Microbiol</source><volume>61</volume><fpage>1556</fpage><lpage>1568</lpage><pub-id pub-id-type="pmid">16930149</pub-id></citation></ref><ref id="ppat-0030100-b068"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>S</given-names></name><name><surname>Inamori</surname><given-names>K</given-names></name><name><surname>Isaji</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration</article-title><source>J Biol Chem</source><volume>281</volume><fpage>32122</fpage><lpage>32130</lpage><pub-id pub-id-type="pmid">16940045</pub-id></citation></ref><ref id="ppat-0030100-b069"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Taniguchi</surname><given-names>N</given-names></name></person-group><year>2004</year><article-title>Regulation of integrin functions by N-glycans</article-title><source>Glycoconj J</source><volume>21</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">15467392</pub-id></citation></ref><ref id="ppat-0030100-b070"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellis</surname><given-names>SL</given-names></name></person-group><year>2004</year><article-title>Variant glycosylation: An underappreciated regulatory mechanism for beta1 integrins</article-title><source>Biochim Biophys Acta</source><volume>1663</volume><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">15157607</pub-id></citation></ref><ref id="ppat-0030100-b071"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>BH</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name><name><surname>Takagi</surname><given-names>J</given-names></name></person-group><year>2003</year><article-title>Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>2403</fpage><lpage>2408</lpage><pub-id pub-id-type="pmid">12604783</pub-id></citation></ref><ref id="ppat-0030100-b072"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Litynska</surname><given-names>A</given-names></name><name><surname>Przybylo</surname><given-names>M</given-names></name><name><surname>Ksiazek</surname><given-names>D</given-names></name><name><surname>Laidler</surname><given-names>P</given-names></name></person-group><year>2000</year><article-title>Differences of alpha3beta1 integrin glycans from different human bladder cell lines</article-title><source>Acta Biochim Pol</source><volume>47</volume><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">11051207</pub-id></citation></ref><ref id="ppat-0030100-b073"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>K</given-names></name><name><surname>Krohkin</surname><given-names>O</given-names></name><name><surname>Mould</surname><given-names>AP</given-names></name><name><surname>Humphries</surname><given-names>MJ</given-names></name><etal/></person-group><year>2005</year><article-title>Evidence for the presence of a low-mass beta1 integrin on the cell surface</article-title><source>J Cell Sci</source><volume>118</volume><fpage>4009</fpage><lpage>4016</lpage><pub-id pub-id-type="pmid">16105875</pub-id></citation></ref><ref id="ppat-0030100-b074"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clement</surname><given-names>M</given-names></name><name><surname>Rocher</surname><given-names>J</given-names></name><name><surname>Loirand</surname><given-names>G</given-names></name><name><surname>Le Pendu</surname><given-names>J</given-names></name></person-group><year>2004</year><article-title>Expression of sialyl-Tn epitopes on beta1 integrin alters epithelial cell phenotype, proliferation and haptotaxis</article-title><source>J Cell Sci</source><volume>117</volume><fpage>5059</fpage><lpage>5069</lpage><pub-id pub-id-type="pmid">15383613</pub-id></citation></ref><ref id="ppat-0030100-b075"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seales</surname><given-names>EC</given-names></name><name><surname>Shaikh</surname><given-names>FM</given-names></name><name><surname>Woodard-Grice</surname><given-names>AV</given-names></name><name><surname>Aggarwal</surname><given-names>P</given-names></name><name><surname>McBrayer</surname><given-names>AC</given-names></name><etal/></person-group><year>2005</year><article-title>A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation</article-title><source>J Biol Chem</source><volume>280</volume><fpage>37610</fpage><lpage>37615</lpage><pub-id pub-id-type="pmid">16157583</pub-id></citation></ref><ref id="ppat-0030100-b076"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Litynska</surname><given-names>A</given-names></name><name><surname>Pochec</surname><given-names>E</given-names></name><name><surname>Hoja-Lukowicz</surname><given-names>D</given-names></name><name><surname>Kremser</surname><given-names>E</given-names></name><name><surname>Laidler</surname><given-names>P</given-names></name><etal/></person-group><year>2002</year><article-title>The structure of the oligosaccharides of alpha3beta1 integrin from human ureter epithelium (HCV29) cell line</article-title><source>Acta Biochim Pol</source><volume>49</volume><fpage>491</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">12362991</pub-id></citation></ref><ref id="ppat-0030100-b077"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>SY</given-names></name><name><surname>Shapiro</surname><given-names>E</given-names></name><name><surname>Kong</surname><given-names>XP</given-names></name><etal/></person-group><year>2006</year><article-title>Distinct glycan structures of uroplakins Ia and Ib: Structural basis for the selective binding of FimH adhesin to uroplakin Ia</article-title><source>J Biol Chem</source><volume>281</volume><fpage>14644</fpage><lpage>14653</lpage><pub-id pub-id-type="pmid">16567801</pub-id></citation></ref><ref id="ppat-0030100-b078"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>RO</given-names></name></person-group><year>2002</year><article-title>Integrins: Bidirectional, allosteric signaling machines</article-title><source>Cell</source><volume>110</volume><fpage>673</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">12297042</pub-id></citation></ref><ref id="ppat-0030100-b079"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brakebusch</surname><given-names>C</given-names></name><name><surname>Fassler</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>The integrin-actin connection, an eternal love affair</article-title><source>EMBO J</source><volume>22</volume><fpage>2324</fpage><lpage>2333</lpage><pub-id pub-id-type="pmid">12743027</pub-id></citation></ref><ref id="ppat-0030100-b080"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shoelson</surname><given-names>SE</given-names></name><name><surname>Sivaraja</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>KP</given-names></name><name><surname>Hu</surname><given-names>P</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name><etal/></person-group><year>1993</year><article-title>Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation</article-title><source>EMBO J</source><volume>12</volume><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">8382612</pub-id></citation></ref><ref id="ppat-0030100-b081"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>HL</given-names></name><name><surname>Janmey</surname><given-names>PA</given-names></name></person-group><year>2003</year><article-title>Phosphoinositide regulation of the actin cytoskeleton</article-title><source>Annu Rev Physiol</source><volume>65</volume><fpage>761</fpage><lpage>789</lpage><pub-id pub-id-type="pmid">12471164</pub-id></citation></ref><ref id="ppat-0030100-b082"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartwig</surname><given-names>JH</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name><name><surname>Carpenter</surname><given-names>CL</given-names></name><name><surname>Janmey</surname><given-names>PA</given-names></name><name><surname>Taylor</surname><given-names>LA</given-names></name><etal/></person-group><year>1995</year><article-title>Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets</article-title><source>Cell</source><volume>82</volume><fpage>643</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">7664343</pub-id></citation></ref><ref id="ppat-0030100-b083"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>S</given-names></name><name><surname>Kaniowska</surname><given-names>D</given-names></name><name><surname>Brakebusch</surname><given-names>C</given-names></name><name><surname>Fassler</surname><given-names>R</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name></person-group><year>2006</year><article-title>Threonine 788 in integrin subunit beta1 regulates integrin activation</article-title><source>Exp Cell Res</source><volume>312</volume><fpage>844</fpage><lpage>853</lpage><pub-id pub-id-type="pmid">16405888</pub-id></citation></ref><ref id="ppat-0030100-b084"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uhlik</surname><given-names>MT</given-names></name><name><surname>Temple</surname><given-names>B</given-names></name><name><surname>Bencharit</surname><given-names>S</given-names></name><name><surname>Kimple</surname><given-names>AJ</given-names></name><name><surname>Siderovski</surname><given-names>DP</given-names></name><etal/></person-group><year>2005</year><article-title>Structural and evolutionary division of phosphotyrosine binding (PTB) domains</article-title><source>J Mol Biol</source><volume>345</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">15567406</pub-id></citation></ref><ref id="ppat-0030100-b085"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calderwood</surname><given-names>DA</given-names></name><name><surname>Fujioka</surname><given-names>Y</given-names></name><name><surname>de Pereda</surname><given-names>JM</given-names></name><name><surname>Garcia-Alvarez</surname><given-names>B</given-names></name><name><surname>Nakamoto</surname><given-names>T</given-names></name><etal/></person-group><year>2003</year><article-title>Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: A structural prototype for diversity in integrin signaling</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>2272</fpage><lpage>2277</lpage><pub-id pub-id-type="pmid">12606711</pub-id></citation></ref><ref id="ppat-0030100-b086"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tadokoro</surname><given-names>S</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name><name><surname>Eto</surname><given-names>K</given-names></name><name><surname>Tai</surname><given-names>V</given-names></name><name><surname>Liddington</surname><given-names>RC</given-names></name><etal/></person-group><year>2003</year><article-title>Talin binding to integrin beta tails: A final common step in integrin activation</article-title><source>Science</source><volume>302</volume><fpage>103</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">14526080</pub-id></citation></ref><ref id="ppat-0030100-b087"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Sarratt</surname><given-names>KL</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>In vivo beta1 integrin function requires phosphorylation-independent regulation by cytoplasmic tyrosines</article-title><source>Genes Dev</source><volume>20</volume><fpage>927</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">16618804</pub-id></citation></ref><ref id="ppat-0030100-b088"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodeau</surname><given-names>AL</given-names></name><name><surname>Berrier</surname><given-names>AL</given-names></name><name><surname>Mastrangelo</surname><given-names>AM</given-names></name><name><surname>Martinez</surname><given-names>R</given-names></name><name><surname>LaFlamme</surname><given-names>SE</given-names></name></person-group><year>2001</year><article-title>A functional comparison of mutations in integrin beta cytoplasmic domains: Effects on the regulation of tyrosine phosphorylation, cell spreading, cell attachment and beta1 integrin conformation</article-title><source>J Cell Sci</source><volume>114</volume><fpage>2795</fpage><lpage>2807</lpage><pub-id pub-id-type="pmid">11683413</pub-id></citation></ref><ref id="ppat-0030100-b089"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Czuchra</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>H</given-names></name><name><surname>Legate</surname><given-names>KR</given-names></name><name><surname>Brakebusch</surname><given-names>C</given-names></name><name><surname>Fassler</surname><given-names>R</given-names></name></person-group><year>2006</year><article-title>Genetic analysis of beta1 integrin &#x0201c;activation motifs&#x0201d; in mice</article-title><source>J Cell Biol</source><volume>174</volume><fpage>889</fpage><lpage>899</lpage><pub-id pub-id-type="pmid">16954348</pub-id></citation></ref><ref id="ppat-0030100-b090"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>T</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Wary</surname><given-names>KK</given-names></name><name><surname>Hook</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>Src kinase has a central role in in vitro cellular internalization of <named-content content-type="genus-species">Staphylococcus aureus</named-content></article-title><source>Cell Microbiol</source><volume>5</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">12780779</pub-id></citation></ref><ref id="ppat-0030100-b091"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gustavsson</surname><given-names>A</given-names></name><name><surname>Armulik</surname><given-names>A</given-names></name><name><surname>Brakebusch</surname><given-names>C</given-names></name><name><surname>Fassler</surname><given-names>R</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><etal/></person-group><year>2002</year><article-title>Role of the beta1-integrin cytoplasmic tail in mediating invasin-promoted internalization of <italic>Yersinia</italic></article-title><source>J Cell Sci</source><volume>115</volume><fpage>2669</fpage><lpage>2678</lpage><pub-id pub-id-type="pmid">12077358</pub-id></citation></ref><ref id="ppat-0030100-b092"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Southgate</surname><given-names>J</given-names></name><name><surname>Kennedy</surname><given-names>W</given-names></name><name><surname>Hutton</surname><given-names>KA</given-names></name><name><surname>Trejdosiewicz</surname><given-names>LK</given-names></name></person-group><year>1995</year><article-title>Expression and in vitro regulation of integrins by normal human urothelial cells</article-title><source>Cell Adhes Commun</source><volume>3</volume><fpage>231</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">8846024</pub-id></citation></ref><ref id="ppat-0030100-b093"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berditchevski</surname><given-names>F</given-names></name></person-group><year>2001</year><article-title>Complexes of tetraspanins with integrins: More than meets the eye</article-title><source>J Cell Sci</source><volume>114</volume><fpage>4143</fpage><lpage>4151</lpage><pub-id pub-id-type="pmid">11739647</pub-id></citation></ref><ref id="ppat-0030100-b094"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sterk</surname><given-names>LM</given-names></name><name><surname>Geuijen</surname><given-names>CA</given-names></name><name><surname>van den Berg</surname><given-names>JG</given-names></name><name><surname>Claessen</surname><given-names>N</given-names></name><name><surname>Weening</surname><given-names>JJ</given-names></name><etal/></person-group><year>2002</year><article-title>Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo</article-title><source>J Cell Sci</source><volume>115</volume><fpage>1161</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">11884516</pub-id></citation></ref><ref id="ppat-0030100-b095"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishiuchi</surname><given-names>R</given-names></name><name><surname>Sanzen</surname><given-names>N</given-names></name><name><surname>Nada</surname><given-names>S</given-names></name><name><surname>Sumida</surname><given-names>Y</given-names></name><name><surname>Wada</surname><given-names>Y</given-names></name><etal/></person-group><year>2005</year><article-title>Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>1939</fpage><lpage>1944</lpage><pub-id pub-id-type="pmid">15677332</pub-id></citation></ref><ref id="ppat-0030100-b096"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lozahic</surname><given-names>S</given-names></name><name><surname>Christiansen</surname><given-names>D</given-names></name><name><surname>Manie</surname><given-names>S</given-names></name><name><surname>Gerlier</surname><given-names>D</given-names></name><name><surname>Billard</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans</article-title><source>Eur J Immunol</source><volume>30</volume><fpage>900</fpage><lpage>907</lpage><pub-id pub-id-type="pmid">10741407</pub-id></citation></ref><ref id="ppat-0030100-b097"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>KC</given-names></name><name><surname>Campellone</surname><given-names>KG</given-names></name></person-group><year>2003</year><article-title>Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic <named-content content-type="genus-species">E. coli</named-content></article-title><source>BMC Mol Biol</source><volume>4</volume><fpage>11</fpage><pub-id pub-id-type="pmid">14672541</pub-id></citation></ref><ref id="ppat-0030100-b098"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>RG</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Gray</surname><given-names>PD</given-names></name><name><surname>Kuang</surname><given-names>J</given-names></name><name><surname>Clayton</surname><given-names>F</given-names></name><etal/></person-group><year>2006</year><article-title>Conditional deletion of beta1 integrins in the intestinal epithelium causes a loss of Hedgehog expression, intestinal hyperplasia, and early postnatal lethality</article-title><source>J Cell Biol</source><volume>175</volume><fpage>505</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">17088430</pub-id></citation></ref><ref id="ppat-0030100-b099"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weitzman</surname><given-names>JB</given-names></name><name><surname>Pasqualini</surname><given-names>R</given-names></name><name><surname>Takada</surname><given-names>Y</given-names></name><name><surname>Hemler</surname><given-names>ME</given-names></name></person-group><year>1993</year><article-title>The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation</article-title><source>J Biol Chem</source><volume>268</volume><fpage>8651</fpage><lpage>8657</lpage><pub-id pub-id-type="pmid">8473308</pub-id></citation></ref><ref id="ppat-0030100-b100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orndorff</surname><given-names>PE</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name></person-group><year>1984</year><article-title>Identification and characterization of a gene product that regulates type 1 piliation in <named-content content-type="genus-species">Escherichia coli</named-content></article-title><source>J Bacteriol</source><volume>160</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">6148338</pub-id></citation></ref><ref id="ppat-0030100-b101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morre</surname><given-names>DJ</given-names></name><name><surname>Morre</surname><given-names>DM</given-names></name></person-group><year>1989</year><article-title>Preparation of mammalian plasma membranes by aqueous two-phase partition</article-title><source>Biotechniques</source><volume>7</volume><fpage>946</fpage><lpage>948</lpage><fpage>950</fpage><lpage>944</lpage><fpage>956</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">2483665</pub-id></citation></ref></ref-list><fn-group><fn id="ack1" fn-type="con"><p><bold>Author contributions.</bold> DSE and MAM conceived and designed the experiments, analyzed the data and wrote the paper. DSE, TAJ, and JLS performed the experiments.</p></fn><fn id="ack2" fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by US National Institutes of Health (NIH) Microbial Pathogenesis Training Grant T32 AI055434-01A1 (to DSE) and by NIH grants DK068585 and DK069526.</p></fn><fn id="ack3" fn-type="conflict"><p><bold>Competing interests.</bold> The authors have declared that no competing interests exist.</p></fn></fn-group></back></article> 